Oncología Digestiva (GIODO)

Castells A, Quintero E, Pellise M, Frias-Arrocha E, Hernandez C, Serra-BurrielM; COLONPREV Study Investigators. Characteristics of Colonoscopy- and FecalImmunochemical Test-Based Screen-Detected Premalignant Neoplastic Lesions:Results From the COLONPREV Study. Gastroenterology. 2026 Jan20:S0016-5085(25)06147-5. doi: 10.1053/j.gastro.2025.10.018. Online ahead ofprint. No abstract available. PubMed PMID: 41556858.

Lopez-Novo A, Amigo J, Dacal A, Remedios-Espino D, Cubiella J, Alvarez-SanchezMV, Ladra-Gonzalez MJ, Fernandez-Lopez F, Alvarez-Castro A, Carles S,Cameselle-Teijeiro JM, Cuatrecasas M, Balaguer F, Castellvi-Bel S,Fernandez-Rozadilla C, Carracedo A, Ruiz-Ponte C. Integration of multi-omics datauncovers novel germline susceptibility candidates in early-onset colorectalcancer. Eur J Hum Genet. 2026 Jan 15. doi: 10.1038/s41431-025-02004-7. Onlineahead of print. PubMed PMID: 41540143.

Alboniga OE, Cubiella J, Bujanda L, Aspichueta P, Blanco ME, Lanza B, AlonsoC, Falcon-Perez JM. Metabolic Signature in Combination with Fecal ImmunochemicalTest as a Non-Invasive Tool for Advanced Colorectal Neoplasia Diagnosis. Cancers(Basel). 2025 Jul 15;17(14):2339. doi: 10.3390/cancers17142339. PubMed PMID:40723223; PubMed Central PMCID: PMC12293502.

Alsina Maqueda M, Teijo Quintans A, Cuatrecasas M, Fernandez Acenero MJ,Fernandez Montes A, Gomez Martin C, Jimenez Fonseca P, Martinez Ciarpaglini C,Rivera Herrero F, Iglesias Coma M. Biomarkers in gastroesophageal cancer 2025: anupdated consensus statement by the Spanish Society of Medical Oncology (SEOM) andthe Spanish Society of Pathology (SEAP). Clin Transl Oncol. 2025Sep;27(9):3580-3594. doi: 10.1007/s12094-025-03865-6. Epub 2025 Mar 12. PubMedPMID: 40072752; PubMed Central PMCID: PMC12399710.

Alsina Maqueda M, Teijo Quintans A, Cuatrecasas M, Fernandez Acenero MJ,Fernandez Montes A, Gomez Martin C, Jimenez Fonseca P, Martinez Ciarpaglini C,Rivera Herrero F, Iglesias Coma M. Correction: Biomarkers in gastroesophagealcancer 2025: an updated consensus statement by the Spanish Society of MedicalOncology (SEOM) and the Spanish Society of Pathology (SEAP). Clin Transl Oncol.2025 Sep;27(9):3833-3835. doi: 10.1007/s12094-025-03941-x. No abstract available.PubMed PMID: 40580409; PubMed Central PMCID: PMC12399445.

Alves JM, Estevez-Gomez N, Pineiro R, Muinelo-Romay L, Mondelo-Macia P,Salgado M, Iglesias-Gomez A, Codesido-Prada L, Diez-Martin A, Cubiella J, PosadaD. Genomic diversity and BCL9L mutational status in circulating tumor cellspredict overall survival in metastatic colorectal cancer. Cell Oncol (Dordr).2025 Oct 6. doi: 10.1007/s13402-025-01109-x. Online ahead of print. PubMed PMID:41051593.

Brea-Iglesias J, Gallardo-Gomez M, Oitaben A, Lazaro-Quintela ME, Leon L,Alves JM, Pino-Gonzalez M, Juaneda-Magdalena L, Garcia-Benito C, Abdulkader I,Muinelo L, Paramio JM, Martinez-Fernandez M. Genomics guiding personalizedfirst-line immunotherapy response in lung and bladder tumors. J Transl Med. 2025Apr 5;23(1):404. doi: 10.1186/s12967-025-06323-7. PubMed PMID: 40188131; PubMedCentral PMCID: PMC11972471.

Bujanda L, Sanchez A, Moreira L, Prat R, Hernandez-Mesa G, Rodriguez-AlcaldeD, Barreiro-Alonso E, Herraiz M, Cubiella J, Izquierdo L, Banales JM, DelfradeOsinaga J, Herreros-Villanueva M. Pancreatic cancer and biliary tract tumors inindividuals with lynch syndrome. Dig Liver Dis. 2025 Oct10:S1590-8658(25)01129-6. doi: 10.1016/j.dld.2025.09.025. Online ahead of print.PubMed PMID: 41076376.

Calafat M, Suria C, Mesonero F, de Francisco R, Yague Caballero C, de la PenaL, Hernandez-Camba A, Marce A, Gallego B, Martin-Vicente N, Rivero M, Iborra M,Guerra I, Carrillo-Palau M, Madero L, Burgueno B, Monfort D, Torres G, Teller M,Ferrer Rosique JA, Vega Villaamil P, Roig C, Ponferrada-Diaz A, Betore Glaria E,Zabana Y, Gisbert JP, Busquets D, Alcaide N, Camps B, Legido J, Gonzalez-Vivo M,Bosca-Watts MM, Perez-Martinez I, Casas Deza D, Guardiola J, Arranz Hernandez L,Navarro M, Gargallo-Puyuelo CJ, Canete F, Manosa M, Domenech E; ENEIDA Registryof GETECCU. HIV Infection Is Associated With a Less Aggressive Phenotype ofInflammatory Bowel Disease: A Multicenter Study of the ENEIDA Registry. Am JGastroenterol. 2025 Feb 1;120(2):431-439. doi: 10.14309/ajg.0000000000002965.Epub 2024 Jul 15. PubMed PMID: 39888687.

Calderon C, Fernandez-Montes A, Gustems M, Roncero L, Pena-Lopez J,Asensio-Martinez E, Munoz-Sanchez M, Jimenez-Fonseca P. Decision-Makingpreferences in advanced cancer patients: associations with sociodemographic andpsychological factors. BMC Palliat Care. 2025 Jul 1;24(1):174. doi:10.1186/s12904-025-01806-2. PubMed PMID: 40597041; PubMed Central PMCID:PMC12211197.

Castells A, Quintero E, Bujanda L, Castan-Cameo S, Cubiella J, Diaz-Tasende J,Lanas A, Ono A, Serra-Burriel M, Frias-Arrocha E, Hernandez C, Jover R, Andreu M,Carballo F, Morillas JD, Salas D, Almazan R, Alonso-Abreu I, Banales JM,Hernandez V, Portillo I, Vanaclocha-Espi M, de la Vega M; COLONPREV studyinvestigators. Effect of invitation to colonoscopy versus faecal immunochemicaltest screening on colorectal cancer mortality (COLONPREV): a pragmatic,randomised, controlled, non-inferiority trial. Lancet. 2025 Apr12;405(10486):1231-1239. doi: 10.1016/S0140-6736(25)00145-X. Epub 2025 Mar 27.PubMed PMID: 40158525.

Castillo-Iturra J, Llach J, Luzko I, Aguilera L, Lopez-Fernandez A, CruellasM, Salces I, Herraiz M, Pinol V, Llort G, Cubiella J, Redondo PD, Poves C,Martinez F, Guerra A, Albeniz E, Montori S, Laguna J, Cuestas A, Cantu-Germano E,Castells A, Fernandez-Esparrach G, Balaguer F, Moreira L. Performance of uppergastrointestinal endoscopy in CDH1 germline pathogenic variant carriers: Amulticenter study. Int J Cancer. 2025 Jul 11. doi: 10.1002/ijc.70044. Onlineahead of print. PubMed PMID: 40650379.

Cordova H, Luzko I, Tejedor-Tejada J, Castillo-Regalado E, Barreiro-Alonso E,Delgado-Guillena P, Diez Redondo P, Galdin M, Garcia-Rodriguez A, Hernandez L,Nunez Rodriguez MH, Seoane A, Jimenez Sanchez J, Cubiella J, Jover R,Rodriguez-D’Jesus A, El Maimouni C, Moreira L, Ortiz O, Llach J,Fernandez-Esparrach G. Prospective validation of the Barcelona scale for theassessment of mucosal cleanliness during upper gastrointestinal endoscopy. TherapAdv Gastroenterol. 2025 Aug 13;18:17562848251363873. doi:10.1177/17562848251363873. eCollection 2025. PubMed PMID: 40821738; PubMedCentral PMCID: PMC12357016.

Cousillas Castineiras A, Gallardo Martin E, Fernandez Montes A, Carmona CamposM, Covela Rua M, Salgado Fernandez M, Pellon Augusto ML, Mendez Mendez JC, BrozosVazquez E, Martinez Lago N. Vitamin D-regulated miRNA expression in tumoral andnormal adjacent tissue of localized gastric cancer patients: the impact onsurvival and time to relapse. Transl Cancer Res. 2025 Jun 30;14(6):3702-3713.doi: 10.21037/tcr-24-2068. Epub 2025 Jun 27. PubMed PMID: 40687227; PubMedCentral PMCID: PMC12268756.

Davila-Pinon P, Diez Martin AI, Nogueira-Rodriguez A, Dominguez-Carbajales R,Fdez-Riverola F, Zarraquinos S, de Castro L, Herrero J, Fernandez N, Vega P,Remedios D, Martinez A, Puga M, Alonso S, Pin N, Garcia-Morales N, Rivas L, LedoA, Macenlle R, Cid L, Rodriguez A, Soto S, Baiocchi F, Perez-Medrano I, SanchezE, Glez-Pena D, Reboiro-Jato M, Lopez-Fernandez H, Cubiella J. ClinicalEvaluation of PolyDeep, A Computer-Aided Detection System: A MulticenterRandomized Tandem Colonoscopy Trial. Diagnostics (Basel). 2025 Oct30;15(21):2751. doi: 10.3390/diagnostics15212751. PubMed PMID: 41226043; PubMedCentral PMCID: PMC12607807.

Davila-Pinon P, Pedrido T, Diez-Martin AI, Herrero J, Puga M, Rivas L, SanchezE, Zarraquinos S, Pin N, Vega P, Soto S, Remedios D, Dominguez-Carbajales R,Fdez-Riverola F, Nogueira-Rodriguez A, Glez-Pena D, Reboiro-Jato M,Lopez-Fernandez H, Cubiella J. PolyDeep Advance 1: Clinical Validation of aComputer-Aided Detection System for Colorectal Polyp Detection with a SecondObserver Design. Diagnostics (Basel). 2025 Feb 13;15(4):458. doi:10.3390/diagnostics15040458. PubMed PMID: 40002609; PubMed Central PMCID:PMC11854325.
Enlace

Delgado Guillena PG, Cuatrecasas M, Montori S, Felipez Varela N, Llach J,Archilla I, Florez-Diez P, Barreiro-Alonso E, Tejedor-Tejada J, Vicente R, SoriaMT, Huerta A, Ortega SP, Nunez H, Patron O, Mangas C, Zaffalon D, Hernandez L,Yip LE, Hontoria G, Hijos G, Domper-Arnal MJ, Zarraquinos S, Herreros De TejadaA, Cordoba A, Cuestas A, Fernandez-Esparrach G, Moreira L, Albeniz E;EpiGASTRIC/EDGAR Consortium. The OLGIMA system for gastric cancer riskassessment. A useful method based on the histological Sydney consensus.Histopathology. 2025 Nov 26. doi: 10.1111/his.70042. Online ahead of print.PubMed PMID: 41293900.

Dominguez-Rovira X, Arnau-Collell C, Gonfaus-Ortiz G, Llargues-Sistac G, MunozJ, Llopis A, Soares de Lima Y, Herrera-Pariente C, Moreira L, Ocana T, Diaz-GayM, Cuatrecasas M, Carballal S, Lopez-Novo A, Fernandez G, Castells A, Bujanda L,Capella G, Cubiella J, Rodriguez-Alcalde D, Valle L, Balaguer F, Ruiz-Ponte C,Bonjoch L, Castellvi-Bel S. Germline pathogenic variants in HIC1 DNA bindingdomains are associated with familial serrated polyposis syndrome. Int J Cancer.2025 Sep 15;157(6):1154-1167. doi: 10.1002/ijc.35492. Epub 2025 May 30. PubMedPMID: 40444741; PubMed Central PMCID: PMC12280854.

Fernandez Calvo O, Munoz Iglesias J, Abou Jokh Casas E, Molina-Diaz A, AnidoHerranz U, Casas Nebra J, Garcia-Bernardo L, Martinez-Breijo S, Lazaro-QuintelaM, Muniz-Garcia G, Vazquez-Estevez S. Recommendations from the GalicianOncological Society and the Galician Society of Nuclear Medicine for the use of177Lu-PSMA-617 radioligand-therapy in prostate cancer. Clin TranslOncol. 2025 Apr;27(4):1383-1397. doi: 10.1007/s12094-024-03662-7. Epub 2024 Sep12. PubMed PMID: 39266875; PubMed Central PMCID: PMC12000182.

Fuentes-Valenzuela E, Baston-Rey I, Garcia-Alonso FJ, Elosua A, Zabalza SanMartin L, Leo Carnerero E, Garcia de la Filia I, Pedraza Perez A, Saiz ChumillasRM, Pascual Oliver A, Munoz Villafranca C, Moreno V, Suarez Ferrer C, Molina G,Ferreiro-Iglesias R, Vega Villaamil P, Gardeazabal Mateos D, Segarra-Ortega JX,Garrido Marin A, Doallo AI, Alonso-Galan H, Brunet-Mas E, Jimenez Garcia N, LopezRomero-Salazar F, Velayos B, Carballo-Folgoso L, Perez Santamaria C, Mata RomanL, Nunez Ortiz A, Barrio J, Barreiro-de Acosta M, Gutierrez-Casbas A.Effectiveness and safety of rectal tacrolimus in patients with ulcerativecolitis. TACRO-TOPIC study of GETECCU. J Crohns Colitis. 2025 May8;19(5):jjaf058. doi: 10.1093/ecco-jcc/jjaf058. PubMed PMID: 40205922.

Garcia Morales N, Gutierrez Morato S, Castillo Cejas C, Fernandez de la VargaM, Menendez Rodriguez M, Aguilera V, Benlloch S, Menendez Rodriguez L, SeoanePillado T, Cubiella J. Adaptation and validation of an abbreviated version of theSIPAT integrated psychosocial risk scale in patients with liver cirrhosiscandidates for liver transplantation (SIPAT-11). Gastroenterol Hepatol. 2025Jan;48(1):502220. doi: 10.1016/j.gastrohep.2024.502220. Epub 2024 Jun 19.English, Spanish. PubMed PMID: 38906324.

Garcia-Alfonso P, Alcaide-Garcia J, Aranda Aguilar E, Elez E, Fernandez MontesA, Garcia Escobar I, Gravalos C, Matos Garcia I, Montagut Viladot C, Santos VivasC, Sastre J, Tarazona N, Jimenez-Fonseca P. Definition of lines of treatment inmetastatic colorectal cancer: a Delphi consensus. Clin Transl Oncol. 2025 Aug 11.doi: 10.1007/s12094-025-03986-y. Online ahead of print. PubMed PMID: 40790286.

Garcia-Alfonso P, Alcaide-Garcia J, Aranda Aguilar E, Elez E, Fernandez MontesA, Garcia Escobar I, Gravalos C, Matos Garcia I, Montagut Viladot C, Santos VivasC, Sastre J, Tarazona N, Jimenez-Fonseca P. Definition of lines of treatment inmetastatic colorectal cancer: a Delphi consensus. Clin Transl Oncol. 2025 Aug 11.doi: 10.1007/s12094-025-03986-y. Online ahead of print. PubMed PMID: 40790286.

Garcia-Alfonso P, Jimenez-Fonseca P, Soto-Alsar J, Baraibar I, Santos C, LaCasta A, Ghanem I, Pulido Cortijo G, Marino Mendez A, Pazo-Cid R, Vera R, MelianM, Alcaide J, Grana B, Paez D, Gallego I, Lobo M, Borregon M, Fernandez Montes A,Martinez de Castro E, Carmona-Bayonas A, Aranda E. Three-year survival follow-upof patients with gastrointestinal cancer treated during the COVID-19 pandemic inSpain: data from the PANDORA-TTD20 study. Oncologist. 2025 Aug 4;30(8):oyae300.doi: 10.1093/oncolo/oyae300. PubMed PMID: 39550209; PubMed Central PMCID:PMC12395236.

Lopez Munoz AM, Gonzalez Flores E, Carral Maseda A, Pimentel Caceres P, AfonsoGomez R, Lopez Lopez C, Jimeno Mate R, Reina Zoilo JJ, Castanon Lopez C, SalgadoFernandez M, Aparicio Urtasun J, Asensio Martinez E, Martin Gomez T. Real-worlddosing patterns of regorafenib for patients with metastatic colorectal cancer inSpain: the RE-SEARCH study. Clin Transl Oncol. 2025 Mar;27(3):1176-1184. doi:10.1007/s12094-024-03630-1. Epub 2024 Aug 11. PubMed PMID: 39127984.

Mateos L, Jimenez-Fonseca P, Gallego J, Lecumberri A, Custodio A, Martinez deCastro E, Hernandez San Gil R, Fernandez Montes A, Limon ML, Vidal-Tocino R, CanoJM, Lopez Robles J, Gil M, Acosta Eyzaguirre D, Marin Zafra G, Merida-Garcia AJ,Francisco Fernandez A, Ribera Fernandez P, Hierro C, Riesco MC, Garcia Araque M,Ruiz Martin M, Pimentel P, Visa L, Cerda P, Granja M, Ruperez Blanco AB,Gutierrez L, Carmona-Bayonas A. Does perioperative FLOT increase cure rates inresectable esophageal adenocarcinoma? A mixture cure model analysis. Br J Cancer.2025 Nov 26. doi: 10.1038/s41416-025-03264-2. Online ahead of print. PubMed PMID:41298815.

Pacheco-Barcia V, Obispo B, Tomas E, Salva de Torres C, Quintanar T, Paez D,Leon-Mateos L, Cancio H, Cortegoso A, Anido U, Quilez A, Tarazona N,Jimenez-Labaig P, Sanchez-Martinez DA, Sesma Goni A, Fernandez-Montes A, Felip E,Rodriguez C, Elez E. Interventional strategies to address burnout in youngmedical oncologists: results from the Resilience-Spanish Society of MedicalOncology (SEOM) Study and a university hospital experience in Spain. Clin TranslOncol. 2025 Dec 23. doi: 10.1007/s12094-025-04171-x. Online ahead of print.PubMed PMID: 41436708.

Regueiro C, Diez Martin AI, Perez S, Davina-Nunez C, Zarraquinos S, RemediosD, Sanchez Gomez CA, Alonso Lorenzo S, Fernandez Poceiro R, de Castro Parga ML,Hernandez Ramirez V, Rodriguez-Blanco A, Sinde E, Fernandez-de-Ana C, Cubiella J.The Effect of Fungal Nutraceutical Supplementation on PostoperativeComplications, Inflammatory Factors and Fecal Microbiota in Patients UndergoingColorectal Cancer Surgery with Curative Intent: A Randomized, Placebo-Controlled,Double-Blind Clinical Trial. Biomedicines. 2025 May 13;13(5):1185. doi:10.3390/biomedicines13051185. PubMed PMID: 40427011; PubMed Central PMCID:PMC12108607.

Sanchez A, Castillo-Iturra J, Roos VH, Duenas N, Pineda M, Moreno L,Rodriguez-Alonso L, Ramon Y Cajal T, Llort G, Pinol V, Lopez Fernandez A, SalcesI, Pico MD, Rivas L, Bujanda L, Garzon M, Pizarro A, Martinez de Castro E,Lopez-Arias MJ, Poves C, Garau C, Rodriguez-Alcalde D, Herraiz M, Alvarez-UrrutiaC, Dacal A, Carrillo-Palau M, Cid L, Ponce M, Barreiro-Alonso E, Saperas E,Aguirre E, Bastiaansen B, Ocana T, Carballal S, Rivero-Sanchez L, Ortiz O,Daca-Alvarez M, Prat-Galito R, Bessa X, Cubiella J, Jover R, Rodriguez-Moranta F,Balmana J, Brunet J, Castells A, Capella G, Ladabaum U, Dekker E, Moreira L,Pellise M, Balaguer F. Gene-Specific Detection Rate of Adenomas and AdvancedAdenomas in Lynch Syndrome. Gastroenterology. 2025 Sep;169(4):663-675. doi:10.1053/j.gastro.2025.03.042. Epub 2025 Apr 30. PubMed PMID: 40315961.

Simoes AR, Carles Gonzalez S, Lopez-Doldan MDC, Duran G, Fernandez-Montes A,Fernandez MP, Salgado Fernandez M, Garcia Mata J, Paez D, Riera P, Guino E,Lopez-Fernandez L, Garcia de Santiago B, Lopez Aspiroz E, Rojas A, Castells A,Castellvi-Bel S, Ruiz Ponte C, Vymetalkova V, Carracedo A, Fernandez-Rozadilla C.Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicityin patients with colorectal cancer. Br J Pharmacol. 2025 Nov;182(21):5340-5354.doi: 10.1111/bph.70051. Epub 2025 Jul 7. PubMed PMID: 40624839.

Toledano-Fonseca M, Cano-Osuna MT, Elez E, Soto-Alsar J, Paez D,Fernandez-Montes A, Grana B, Salud A, Yubero A, Macias I, Quintero G, Lopez-LopezC, Fernandez-Rodriguez T, Garcia-Ortiz MV, Sastre J, Garcia-Alfonso P,Rodriguez-Ariza A, Aranda E; Spanish Cooperative Group for the Treatment ofDigestive Tumours (TTD). Circulating hsa-miR-29c-3p and VEGF-A levels predict theresponse to FOLFIRI plus aflibercept in elderly metastatic colorectal cancerpatients. Eur J Clin Invest. 2025 Aug 1:e70103. doi: 10.1111/eci.70103. Onlineahead of print. PubMed PMID: 40747746.

Brotons A, Mangas-Sanjuan C, Cubiella J, Cid-Gomez L, Diez-Redondo P, SeoaneA, Garcia-Mateo S, Suarez A, Nicolas-Perez D, Lumbreras B, Mira JJ, Sola-Vera J,Jover R; QUALISCOPIA study investigators. Colonoscopy Satisfaction and SafetyQuestionnaire based on patient experience (CSSQP): A valuable quality tool forall colonoscopies. Gastroenterol Hepatol. 2024 Jan;47(1):1-13. doi:10.1016/j.gastrohep.2023.02.003. Epub 2023 Feb 23. English, Spanish. PubMed PMID:36841528.

Davila-Pinon P, Nogueira-Rodriguez A, Diez-Martin AI, Codesido L, Herrero J,Puga M, Rivas L, Sanchez E, Fdez-Riverola F, Glez-Pena D, Reboiro-Jato M,Lopez-Fernandez H, Cubiella J. Optical diagnosis in still images of colorectalpolyps: comparison between expert endoscopists and PolyDeep, a Computer-AidedDiagnosis system. Front Oncol. 2024 May 23;14:1393815. doi:10.3389/fonc.2024.1393815. eCollection 2024. PubMed PMID: 38846970; PubMedCentral PMCID: PMC11153726.

Ferreiro-Iglesias R, Porto Silva S, Marin S, Casanova MJ, Manosa M,Gonzalez-Munoza C, de Francisco R, Caballol B, Arias L, Piqueras M, Zabana Y,Rivero M, Calvet X, Mesonero F, Varela Trastoy P, Busta Nistal R, Gomez PerosanzR, Vega P, Gonzalez-Vivo M, Iborra M, Bermejo F, Madero L, Rodriguez-Lago I,Rodriguez Gonzalez M, Vera I, Ponferrada Diaz A, Vela M, Torrealba Medina L, VanDomselaar M, Gomollon F, Iglesias E, Gisbert JP, Calafat M, Giordano A,Perez-Martinez I, Ricart E, Sicilia B, Mena R, Esteve M, Rivas C, Brunet-Mas E,Fernandez C, de Jorge Turrion MA, Velayos Jimenez B, Quinones Calvo M, RegueiroExposito C, Marquez-Mosquera L, Nos P (…) Barreiro-de Acosta M; ENEIDA project sponsored by GETECCU.Need for therapeutic escalation in patients with refractory ulcerative proctitis:Results from the PROCU study of the ENEIDA registry. Aliment Pharmacol Ther. 2024Sep;60(5):604-612. doi: 10.1111/apt.18133. Epub 2024 Jun 28. PubMed PMID:38943230.

Gallardo-Gomez M, Costas-Rios L, Garcia-Prieto CA, Alvarez-Rodriguez L,Bujanda L, Barrero M, Castells A, Balaguer F, Jover R, Esteller M, Tardio BaigesA, Gonzalez-Carrero Fojon J, Cubiella J, De Chiara L. Serum DNA methylome of thecolorectal cancer serrated pathway enables non-invasive detection. Mol Oncol.2024 Nov;18(11):2696-2713. doi: 10.1002/1878-0261.13573. Epub 2024 Jan 10. PubMedPMID: 38129291; PubMed Central PMCID: PMC11547225.

Menendez Rodriguez M, Garcia-Morales N, Seoane Pillado T, Garau Ramirez J,Traver Salvador A, Hervas Jimenez Y, Fernandez-Dominguez MJ, Menendez Villalva C,Cubiella J. Influence of social support and stressful life events on adherence tocolorectal cancer screening using faecal occult blood test in Spanish medium riskpopulation. Gastroenterol Hepatol. 2024 Jan;47(1):14-23. doi:10.1016/j.gastrohep.2023.02.004. Epub 2023 Feb 24. English, Spanish. PubMed PMID:36842551.

Salgado Fernandez M, Reboredo Lopez M, Covela Rua M, Candamio S,Gonzalez-Villarroel P, Sanchez-Cousido LF, Grana B, Carral-Maseda A,Cameselle-Garcia S, Varela Pose V, Gallardo-Martin ME, Martinez-Lago N; GalicianGroup of Research in Digestive Tumors (GITuD). Rechallenge with Anti-EGFRTreatment in RAS/BRAF wt Metastatic Colorectal Cancer (mCRC) in Real ClinicalPractice: Experience of the GITuD Group. Target Oncol. 2024 Jul;19(4):565-573.doi: 10.1007/s11523-024-01062-z. Epub 2024 May 23. PubMed PMID: 38780742.

Tejido C, Puga M, Regueiro C, Francisco M, Rivas L, Sanchez E. Evaluation ofthe effectiveness and safety of single-operator cholangiopancreatoscopy with theSpyGlass system. Gastroenterol Hepatol. 2024 Feb;47(2):170-178. doi:10.1016/j.gastrohep.2023.06.001. Epub 2023 Jun 8. English, Spanish. PubMed PMID:37301507.

Blanco-Miguez A, Marcos-Fernandez R, Guadamuro-Garcia L, Fdez-Riverola F,Cubiella J, Lourenco A, Margolles A, Sanchez B. Targeted depletion ofpks+ bacteria from a fecal microbiota using specific antibodies.mSystems. 2023 Jun 29;8(3):e0007923. doi: 10.1128/msystems.00079-23. Epub 2023May 23. PubMed PMID: 37219498; PubMed Central PMCID: PMC10308883.

Cubiella J, Calderon-Cruz B, Almazan R, Gomez-Amorin A. Impact of the COVID-19Pandemic on the Diagnosis of Colorectal Cancer within a Population-BasedOrganized Screening Program. Cancers (Basel). 2023 Oct 4;15(19):4853. doi:10.3390/cancers15194853. PubMed PMID: 37835547; PubMed Central PMCID:PMC10571915.

Gallardo-Gomez M, Rodriguez-Girondo M, Planell N, Moran S, Bujanda L, EtxartA, Castells A, Balaguer F, Jover R, Esteller M, Cubiella J, Gomez-Cabrero D, DeChiara L. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasivebiomarkers for the early detection of colorectal cancer and advanced adenomas.Clin Epigenetics. 2023 Oct 4;15(1):157. doi: 10.1186/s13148-023-01570-1. PubMedPMID: 37794510; PubMed Central PMCID: PMC10552320.

Garcia Morales N, Fernandez de la Varga M, Pumares Perez J, Menendez RodriguezM, Gutierrez Morato S, Castillo Cejas C, Aguilera V, Benlloch S, MenendezRodriguez L, Seoane Pillado T, Pin Vieito N, Cubiella J. Inadequate socialsupport decreases survival in decompensated liver cirrhosis patients.Gastroenterol Hepatol. 2023 Jan;46(1):28-38. doi:10.1016/j.gastrohep.2022.04.006. Epub 2022 May 13. English, Spanish. PubMed PMID:35569542.
Enlace

Juul FE, Garborg K, Nesbakken E, Loberg M, Wieszczy P, Cubiella J, Kalager M,Kaminski MF, Erichsen R, Adami HO, Ferlitsch M, Furholm SKB, Zauber AG, QuinteroE, Bugajski M, Holme O, Dekker E, Jover R, Bretthauer M. Rates of repeatedcolonoscopies to clean the colon from low-risk and high-risk adenomas: resultsfrom the EPoS trials. Gut. 2023 May;72(5):951-957. doi:10.1136/gutjnl-2022-327696. Epub 2022 Oct 28. PubMed PMID: 36307178.

Mangas-Sanjuan C, de-Castro L, Cubiella J, Diez-Redondo P, Suarez A, PelliseM, Fernandez N, Zarraquinos S, Nunez-Rodriguez H, Alvarez-Garcia V, Ortiz O,Sala-Miquel N, Zapater P, Jover R; CADILLAC study investigators. Role ofArtificial Intelligence in Colonoscopy Detection of Advanced Neoplasias : ARandomized Trial. Ann Intern Med. 2023 Sep;176(9):1145-1152. doi:10.7326/M22-2619. Epub 2023 Aug 29. PubMed PMID: 37639723.

Menendez Rodriguez M, Garcia-Morales N, Seoane Pillado T, Garau Ramirez J,Traver Salvador A, Hervas Jimenez Y, Pin Vieito N, Menendez Rodriguez L, CubiellaJ. Perceived barriers and benefits in the participation in faecal occult bloodtest colorectal cancer screening programme. Gastroenterol Hepatol. 2023Mar;46(3):185-194. doi: 10.1016/j.gastrohep.2022.05.003. Epub 2022 May 20.English, Spanish. PubMed PMID: 35605825.
Enlace

Moreno-Sanchez M, Cubiella J, Fernandez Esparrach G, Marin-Gabriel JC.Image-enhanced endoscopy in the diagnosis of gastric premalignant conditions andgastric cancer. Gastroenterol Hepatol. 2023 May;46(5):397-409. doi:10.1016/j.gastrohep.2022.06.007. Epub 2022 Jun 30. English, Spanish. PubMed PMID:35780957.

Soares de Lima Y, Arnau-Collell C, Munoz J, Herrera-Pariente C, Moreira L,Ocana T, Diaz-Gay M, Franch-Exposito S, Cuatrecasas M, Carballal S, Lopez-Novo A,Moreno L, Fernandez G, Diaz de Bustamante A, Peters S, Sommer AK, Spier I, TePaske IBAW, van Herwaarden YJ, Castells A, Bujanda L, Capella G, Steinke-Lange V,Mahmood K, Joo JE, Arnold J, Parry S, Macrae FA, Winship IM, Rosty C, Cubiella J,Rodriguez-Alcalde D, Holinski-Feder E, de Voer R, Buchanan DD, Aretz S,Ruiz-Ponte C, Valle L, Balaguer F, Bonjoch L, Castellvi-Bel S. Germline mutationsin WNK2 could be associated with serrated polyposis syndrome. J MedGenet. 2023 Jun;60(6):557-567. doi: 10.1136/jmg-2022-108684. Epub 2022 Oct 21.PubMed PMID: 36270769; PubMed Central PMCID: PMC10313964.

Alves JM, Estevez-Gomez N, Valecha M, Prado-Lopez S, Tomas L, Alvarino P,Pineiro R, Muinelo-Romay L, Mondelo-Macia P, Salgado M, Iglesias-Gomez A,Codesido-Prada L, Cubiella J, Posada D. Comparative analysis of capture methodsfor genomic profiling of circulating tumor cells in colorectal cancer. Genomics.2022 Nov;114(6):110500. doi: 10.1016/j.ygeno.2022.110500. Epub 2022 Oct 4. PubMedPMID: 36202322.

Cubiella J. Closing the gap for post-colonoscopy colorectal cancer. LancetGastroenterol Hepatol. 2022 Aug;7(8):694-695. doi: 10.1016/S2468-1253(22)00128-5.Epub 2022 May 9. No abstract available. PubMed PMID: 35550251.

Cubiella J. Post-polypectomy surveillance: walking in the fog. Endoscopy. 2022Oct;54(10):959-960. doi: 10.1055/a-1849-2294. Epub 2022 Jun 3. No abstractavailable. PubMed PMID: 35668661.

De Chiara L, Barcia-Castro L, Gallardo-Gomez M, Paez de la Cadena M,Martinez-Zorzano VS, Rodriguez-Berrocal FJ, Bujanda L, Etxart A, Castells A,Balaguer F, Jover R, Cubiella J, Cordero OJ. Evaluation of Blood Soluble CD26 asa Complementary Biomarker for Colorectal Cancer Screening Programs. Cancers(Basel). 2022 Sep 20;14(19):4563. doi: 10.3390/cancers14194563. PubMed PMID:36230486; PubMed Central PMCID: PMC9559671.

Elez E, Gomez-Espana MA, Gravalos C, Garcia-Alfonso P, Ortiz-Morales MJ, LosaF, Diaz IA, Grana B, Toledano-Fonseca M, Valladares-Ayerbes M, Polo E, Salgado M,Martinez de Castro E, Safont MJ, Salud A, Ruiz-Casado A, Tabernero J, Riesco MDC,Rodriguez-Ariza A, Aranda E. Effect of aflibercept plus FOLFIRI and potentialefficacy biomarkers in patients with metastatic colorectal cancer: the POLAFtrial. Br J Cancer. 2022 Apr;126(6):874-880. doi: 10.1038/s41416-021-01638-w.Epub 2021 Dec 22. PubMed PMID: 34937947; PubMed Central PMCID: PMC8927487.

Fernandez Montes A, Elez E, Vivancos A, Martinez N, Gonzalez P, Covela M, dela Camara J, Cousillas A, Mendez JC, Grana B, Aranda E. Monitoring of RAS mutantclones in plasma of patients with RAS mutant metastatic colorectal cancer. ClinTransl Oncol. 2022 Jun;24(6):1209-1214. doi: 10.1007/s12094-021-02767-7. Epub2022 Jan 7. PubMed PMID: 34997474; PubMed Central PMCID: PMC9107427.

Fernandez-Montes A, Alcaide J, Alsina M, Custodio AB, Franco LF, GallegoPlazas J, Gomez-Martin C, Richart P, Rivera F, Martin-Richard M. SEOM-GEMCAD-TTDClinical Guideline for the diagnosis and treatment of esophageal cancer (2021).Clin Transl Oncol. 2022 Apr;24(4):658-669. doi: 10.1007/s12094-022-02801-2. Epub2022 Mar 26. PubMed PMID: 35347573; PubMed Central PMCID: PMC8986732.

Mangas-Sanjuan C, Seoane A, Alvarez-Gonzalez MA, Lue A, Suarez A,Alvarez-Garcia V, Bujanda L, Portillo I, Gonzalez N, Cid-Gomez L, Cubiella J,Rodriguez-Camacho E, Ponce M, Diez-Redondo P, Herraiz M, Pellise M, Ono A,Baile-Maxia S, Medina-Prado L, O M, Zapater P, Jover R; QUALISCOPIA StudyInvestigators. Factors associated with lesion detection in colonoscopy amongdifferent indications. United European Gastroenterol J. 2022 Nov;10(9):1008-1019.doi: 10.1002/ueg2.12325. Epub 2022 Oct 27. PubMed PMID: 36300971; PubMed CentralPMCID: PMC9731659.

Menéndez Rodríguez M, Garau Ramírez J, Traver Salvador A, Hervás Jiménez Y, García Morales N, Seoane Pillado T, Pin Vieito N, Vega Villaamil P, Montes Martínez A, Cubiella J. Rawl’s questionnaire spanish validation for colorectal cancer screening with faecal occult blood testing. Gastroenterol Hepatol. 2022 Feb;45(2):106–13. PMID: 34023478. DOI: 10.1016/j.gastrohep.2021.04.001. http://www.ncbi.nlm.nih.gov/pubmed/34023478
Enlace

Nogueira-Rodríguez A, Domínguez-Carbajales R, Campos-Tato F, Herrero J, Puga M, Remedios D, Rivas L, Sánchez E, Iglesias Á, Cubiella J, Fdez-Riverola F, López-Fernández H, Reboiro-Jato M, Glez-Peña D. Real-time polyp detection model using convolutional neural networks. Neural Comput Appl. 2022 Jul;34(13):10375–96. DOI: 10.1007/s00521-021-06496-4. http://doi.org/10.1007/s00521-021-06496-4%0A
Enlace

Pin-Vieito N, Tejido-Sandoval C, de Vicente-Bielza N, Sanchez-Gomez C,Cubiella J. Faecal immunochemical tests safely enhance rational use of resourcesduring the assessment of suspected symptomatic colorectal cancer in primary care:systematic review and meta-analysis. Gut. 2022 May;71(5):950-960. doi:10.1136/gutjnl-2021-324856. Epub 2021 Jun 9. PubMed PMID: 34108236.

Regueiro C, Codesido L, Garcia-Nimo L, Zarraquinos S, Remedios D,Rodriguez-Blanco A, Sinde E, Fernandez-de-Ana C, Cubiella J. Effect of theNutraceutical Micodigest 2.0 on the Complication Rate of Colorectal CancerSurgery With Curative Intent: Protocol for a Placebo-Controlled Double-blindRandomized Clinical Trial. JMIR Res Protoc. 2022 May 16;11(5):e34292. doi:10.2196/34292. PubMed PMID: 35576566; PubMed Central PMCID: PMC9152712.

Rodriguez-Martinez L, Regueiro C, Amhaz-Escanlar S, Pena C, Herbello-HermeloP, Moreda-Pineiro A, Rodriguez-Garcia J, Mera-Varela A, Perez-Pampin E, GonzalezA. Antibodies against 4 Atypical Post-Translational Protein Modifications inPatients with Rheumatoid Arthritis. Diagnostics (Basel). 2022 Jan 29;12(2):352.doi: 10.3390/diagnostics12020352. PubMed PMID: 35204444; PubMed Central PMCID:PMC8870974.

Salgado M, Brozos-Vazquez E, Campos B, Gonzalez-Villarroel P, Perez ME,Vazquez-Tunas ML, Arias D. Venous Thromboembolism In Cancer Patients: «FromEvidence to Care». Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221098717.doi: 10.1177/10760296221098717. PubMed PMID: 35538861; PubMed Central PMCID:PMC9102132.

Sánchez A, Roos VH, Navarro M, Pineda M, Caballol B, Moreno L, Carballal S, Rodríguez-Alonso L, Ramon Y Cajal T, Llort G, Piñol V, López-Fernández A, Salces I, Picó MD, Rivas L, Bujanda L, Garzon M, Pizarro A, Martinez de Castro E, López-Arias MJ, Poves C, Garau C, Rodriguez-Alcalde D, Herraiz M, Alvarez-Urrutia C, Dacal A, Carrillo-Palau M, Cid L, Ponce M, Barreiro-Alonso E, Saperas E, Aguirre E, Romero C, Bastiaansen B, Gonzalez-Acosta M, Morales-Romero B, Ocaña T, Rivero-Sánchez L, Jung G, Bessa X, Cubiella J, Jover R, Rodríguez-Moranta F, Balmaña J, Brunet J, Castells A, Dekker E, Capella G, Serra-Burriel M, Moreira L, Pellise M, Balaguer F. Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome. Clin Gastroenterol Hepatol. 2022 Nov;20(3):611-621.e9. PMID: 33157315. DOI: 10.1016/j.cgh.2020.11.002. http://www.ncbi.nlm.nih.gov/pubmed/33157315
Enlace

Telleria O, Alboniga OE, Clos-Garcia M, Nafria-Jimenez B, Cubiella J, BujandaL, Falcon-Perez JM. A Comprehensive Metabolomics Analysis of Fecal Samples fromAdvanced Adenoma and Colorectal Cancer Patients. Metabolites. 2022 Jun15;12(6):550. doi: 10.3390/metabo12060550. PubMed PMID: 35736483; PubMed CentralPMCID: PMC9229737.

Zaragoza-Huesca D, Garrido-Rodriguez P, Jimenez-Fonseca P, Martinez de CastroE, Sanchez-Canovas M, Visa L, Custodio A, Fernandez-Montes A, Penas-Martinez J,Morales Del Burgo P, Gallego J, Luengo-Gil G, Vicente V, Martinez-Martinez I,Carmona-Bayonas A. Identification of Thrombosis-Related Genes in Patients withAdvanced Gastric Cancer: Data from AGAMENON-SEOM Registry. Biomedicines. 2022 Jan11;10(1):148. doi: 10.3390/biomedicines10010148. PubMed PMID: 35052827; PubMedCentral PMCID: PMC8773420.

Arias Ron D, Areses Manrique MC, Mosquera Martínez J, García González J, Afonso Afonso FJ, Lázaro Quintela M, Fernández Núñez N, Azpitarte Raposeiras C, Amenedo Gancedo M, Santomé Couto L, García Campelo MR, Muñoz Iglesias J, Ruiz Bañobre J, Vilchez Simo R, Casal Rubio J, Campos Balea B, Carou Frieiro I, Alonso-Jaudenes Curbera G, Anido Herranz U, García Mata J, Fírvida Pérez JL. Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group. J Geriatr Oncol. 2021 Apr;12(3):410–5. PMID: 33357975. DOI: 10.1016/j.jgo.2020.11.010. http://www.ncbi.nlm.nih.gov/pubmed/33357975
Enlace

Chandrapalan S, Bosch S, Cubiella J, Guardiola J, Kimani P, Mulder C, Persaud K, de Meij TGJ, Altomare DF, Brenner H, de Boer NKH, Ricciardiello L, Arasaradnam RP. Systematic review with meta-analysis: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer. Aliment Pharmacol Ther. 2021;54(1):14–23. PMID: 34004036. DOI: 10.1111/apt.16405. http://www.ncbi.nlm.nih.gov/pubmed/34004036
Enlace

Chaparro M, Garre A, Núñez Ortiz A, Diz-Lois Palomares MT, Rodríguez C, Riestra S, Vela M, Benítez JM, Fernández Salgado E, Sánchez Rodríguez E, Hernández V, Ferreiro-Iglesias R, Ponferrada Díaz Á, Barrio J, Huguet JM, Sicilia B, Martín-Arranz MD, Calvet X, Ginard D, Alonso-Abreu I, Fernández-Salazar L, Varela Trastoy P, Rivero M, Vera-Mendoza I, Vega P, Navarro P, Sierra M, Cabriada JL, Aguas M, Vicente R, Navarro-Llavat M, Echarri A, Gomollón F, Guerra Del Río E, Piñero C, Casanova MJ, Spicakova K, Ortiz de Zarate J, Torrella Cortés E, Gutiérrez A, Alonso-Galán H, Hernández-Martínez Á, Marrero JM, Lorente Poyatos R, Calafat M, Martí Romero L, Robledo P, Bosch O, Jiménez N, Esteve Comas M, Duque JM, Fuentes Coronel AM, Josefa Sampedro M, Sesé Abizanda E, Herreros Martínez B, Pozzati L, Fernández Rosáenz H, Crespo Suarez B, López Serrano P, Lucendo AJ, Muñoz Vicente M, Bermejo F, Ramírez Palanca JJ, Menacho M, Carmona A, Camargo R, Torra Alsina S, Maroto N, Nerín de la Puerta J, Castro E, Marín-Jiménez I, Bot
Enlace

Cruz A, Carvalho CM, Cunha A, Crespo A, Iglesias A, Garcia-Nimo L, Freitas PP,Cubiella J. Faecal Diagnostic Biomarkers for Colorectal Cancer. Cancers (Basel).2021 Nov 7;13(21):5568. doi: 10.3390/cancers13215568. PubMed PMID: 34771730;PubMed Central PMCID: PMC8582677.

Cubiella J, Gonzalez A, Almazan R, Rodriguez-Camacho E, Zubizarreta R,Pena-Rey Lorenzo I. Overtreatment in nonmalignant lesions detected in acolorectal cancer screening program: a retrospective cohort study. BMC Cancer.2021 Jul 29;21(1):869. doi: 10.1186/s12885-021-08606-w. PubMed PMID: 34325674;PubMed Central PMCID: PMC8323280.

Cubiella J, Lorenzo M, Baiocchi F, Tejido C, Conde A, Sande-Meijide M, CastroM. Impact of a colorectal cancer screening program implantation on delays andprognosis of non-screening detected colorectal cancer. World J Gastroenterol.2021 Oct 21;27(39):6689-6700. doi: 10.3748/wjg.v27.i39.6689. PubMed PMID:34754161; PubMed Central PMCID: PMC8554396.

Cubiella J, Pérez Aisa Á, Cuatrecasas M, Díez Redondo P, Fernández Esparrach G, Marín-Gabriel JC, Moreira L, Núñez H, Pardo López ML, Rodríguez de Santiago E, Rosón P, Sanz Anquela JM, Calvet X, en representación de la Asociación Española de Gastroenterología la SE de ED y la SE de AP. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP. Gastroenterol Hepatol. 2021 Jan;44(1):67–86. PMID: 33252332. DOI: 10.1016/j.gastrohep.2020.08.004. http://www.ncbi.nlm.nih.gov/pubmed/33252332
Enlace

Dolz Abadía C, Pons Beltrán V, Sánchez Hernández E, Sánchez Ocaña R, Gornals J, Foruny JR, Vila J, González-Huix F. CHOLANGIOPANCREATOSCOPY. WORKING PROTOCOL. SEED Recommendations. Rev Esp Enferm Dig. 2021 Mar;113(3):207–14. PMID: 33267604. DOI: 10.17235/reed.2020.7531/2020. http://www.ncbi.nlm.nih.gov/pubmed/33267604
Enlace

Fernández Montes A, Martinez-Lago N, de la Cámara Gomez J, Brozos Vázquez EM, Candamio Folgar S, Carmona Campos M, Cousillas Castiñeiras A, Covela Rúa M, Gallardo Martín E, González Villarroel P, Graña Suarez B, Jorge Fernández M, Pellón Augusto ML, Quintero Aldana G, Romero Reinoso C, Salgado Fernández M, Vázquez Rivera F, Ayuso Álvarez A, Culqui DR, Méndez Méndez JC, RIGhT-Sens Working Group. Do Clinical Trials Meet Current Care Needs? Views of Digestive Oncology Specialists in Galicia (Spain) Using the Delphi Method. Healthc (Basel, Switzerland). 2021 Jun;9(6):665. PMID: 34205026. DOI: 10.3390/healthcare9060665. http://www.ncbi.nlm.nih.gov/pubmed/34205026
Enlace

Fernández-Esparrach G, Marín-Gabriel JC, Díez Redondo P, Núñez H, Rodríguez de Santiago E, Rosón P, Calvet X, Cuatrecasas M, Cubiella J, Moreira L, Pardo López ML, Pérez Aisa Á, Sanz Anquela JM, en representación de la Asociación Española de Gastroenterología la SE de ED y la SE de AP. Quality in diagnostic upper gastrointestinal endoscopy for the detection and surveillance of gastric cancer precursor lesions: Position paper of AEG, SEED and SEAP. Gastroenterol Hepatol. 2021;44(6):448–64. PMID: 33609597. DOI: 10.1016/j.gastrohep.2021.01.002. http://www.ncbi.nlm.nih.gov/pubmed/33609597
Enlace

Gallardo-Gómez M, De Chiara L, Álvarez-Chaver P, Cubiella J. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method. Expert Rev Anticancer Ther. 2021 Jul;21(7):723–38. PMID: 33507120. DOI: 10.1080/14737140.2021.1882858. http://www.ncbi.nlm.nih.gov/pubmed/33507120
Enlace

García-Foncillas J, Argente J, Bujanda L, Cardona V, Casanova B, Fernández-Montes A, Horcajadas JA, Iñiguez A, Ortiz A, Pablos JL, Pérez Gómez MV. Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview. Mol Diagn Ther. 2021 Sep;25(5):563–76. PMID: 34331269. DOI: 10.1007/s40291-021-00544-4. http://www.ncbi.nlm.nih.gov/pubmed/34331269
Enlace

Jimenez-Fonseca P, Carmona-Bayonas A, Martinez-Torron A, Alsina M, Custodio A, Serra O, Cacho Lavin D, Limón ML, Sauri T, López F, Visa L, Granja M, Martínez Lago N, Arrazubi V, Vidal Tocino R, Hernandez R, Aguado G, Cano JM, Martín Carnicero A, Mangas M, Pimentel P, Fernández Montes A, Macias Declara I, Longo F, Ramchandani A, Martín Richard M, Hurtado A, Azkarate A, Hernández Pérez C, Serrano R, Gallego J, AGAMENON-SEOM study group. External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry. Ther Adv Med Oncol. 2021;13:17588359211019672. PMID: 34211587. DOI: 10.1177/17588359211019672. http://www.ncbi.nlm.nih.gov/pubmed/34211587
Enlace

Lorenzo-Pouso AI, Castelo-Baz P, Rodriguez-Zorrilla S, Pérez-Sayáns M, Vega P. Association between periodontal disease and inflammatory bowel disease: a systematic review and meta-analysis. Acta Odontol Scand. 2021 Jul;79(5):344–53. PMID: 33370548. DOI: 10.1080/00016357.2020.1859132. http://www.ncbi.nlm.nih.gov/pubmed/33370548
Enlace

Luque R, Benavides M, Del Barco S, Egaña L, García-Gómez J, Martínez-García M, Pérez-Segura P, Pineda E, Sepúlveda JM, Vieito M. SEOM clinical guideline for management of adult medulloblastoma (2020). Clin Transl Oncol. 2021 May;23(5):940–7. PMID: 33792841. DOI: 10.1007/s12094-021-02581-1. http://www.ncbi.nlm.nih.gov/pubmed/33792841
Enlace

Menéndez-Rodríguez M, García-Morales N, López-Gómez B, Garcia-Verdugo N, Seone-Pillado T, Menéndez-Villalva C, Cubiella-Fernández J. Estilo de vida y actividades preventivas en el cribado de cancer colorrectal. Cad atención primaria. 2021;21(4):15–22. https://revista.agamfec.com/estilo-de-vida-y-actividades-preventivas-en-el-cribado-de-cancer-colorrectal/
Enlace

Nogueira-Rodríguez A, Domínguez-Carbajales R, López-Fernández H, Iglesias Á, Cubiella J, Fdez-Riverola F, Reboiro-Jato M, Glez-Peña D. Deep Neural Networks approaches for detecting and classifying colorectal polyps. Neurocomputing. 2021 Jan;423:721–34. DOI: 10.1016/j.neucom.2020.02.123. https://doi.org/10.1016/j.neucom.2020.02.123%0A
Enlace

Peña-Rey I, Almazán R, Rodríguez-Camacho E, Cubiella J, Grupo de Trabajo del Programa de Detección Precoz de Cáncer Colorrectal de Galicia (Eloy Sanchez; Juan Turnes; Victoria Álvarez; J Ignacio Rodríguez Prada). Resumption of endoscopy in the Galician colorectal cancer screening programme after the COVID-19 lock down: patient safety results. Rev Esp Enferm Dig. 2021;113(2):119–21. PMID: 33393333. DOI: 10.17235/reed.2020.7647/2020. http://www.ncbi.nlm.nih.gov/pubmed/33393333
Enlace

Pin-Vieito N, García Nimo L, Bujanda L, Román Alonso B, Gutierrez-Stampa MÁ, Aguilar-Gama V, Portillo I, Cubiella J. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study. United Eur Gastroenterol J. 2021 Aug;9(2):256–67. PMID: 32778002. DOI: 10.1177/2050640620949714. http://www.ncbi.nlm.nih.gov/pubmed/32778002
Enlace

Regueiro C, Almazán R, Portillo I, Besó M, Tourne-Garcia C, Rodríguez-Camacho E, Ono A, Gómez-Amorín Á, Cubiella J. Polyprev: Randomized, Multicenter, Controlled Trial Comparing Fecal Immunochemical Test with Endoscopic Surveillance after Advanced Adenoma Resection in Colorectal Cancer Screening Programs: A Study Protocol. Diagnostics. 2021 Aug;11(9):1520. DOI: 10.3390/diagnostics11091520. https://www.mdpi.com/2075-4418/11/9/1520
Enlace

Regueiro C, Casares-Marfil D, Lundberg K, Knevel R, Acosta-Herrera M,Rodriguez-Rodriguez L, Lopez-Mejias R, Perez-Pampin E, Triguero-Martinez A, NunoL, Ferraz-Amaro I, Rodriguez-Carrio J, Lopez-Pedrera R, Robustillo-Villarino M,Castaneda S, Remuzgo-Martinez S, Alperi M, Alegre-Sancho JJ, Balsa A,Gonzalez-Alvaro I, Mera A, Fernandez-Gutierrez B, Gonzalez-Gay MA, Trouw LA,Gronwall C, Padyukov L, Martin J, Gonzalez A. HLA-B*08 Identified as the MostProminently Associated Major Histocompatibility Complex Locus forAnti-Carbamylated Protein Antibody-Positive/Anti-Cyclic CitrullinatedPeptide-Negative Rheumatoid Arthritis. Arthritis Rheumatol. 2021Jun;73(6):963-969. doi: 10.1002/art.41630. Epub 2021 Apr 23. PubMed PMID:33381897.

Regueiro C, Nuno L, Triguero-Martinez A, Ortiz AM, Villalba A, Boveda MD,Martinez-Feito A, Conde C, Balsa A, Gonzalez-Alvaro I, Gonzalez A. Increaseddisease activity in early arthritis patients with anti-carbamylated proteinantibodies. Sci Rep. 2021 May 11;11(1):9945. doi: 10.1038/s41598-021-89502-y.PubMed PMID: 33976334; PubMed Central PMCID: PMC8113595.

Soares de Lima Y, Arnau-Collell C, Díaz-Gay M, Bonjoch L, Franch-Expósito S, Muñoz J, Moreira L, Ocaña T, Cuatrecasas M, Herrera-Pariente C, Carballal S, Moreno L, Díaz de Bustamante A, Castells A, Bujanda L, Cubiella J, Rodríguez-Alcalde D, Balaguer F, Castellví-Bel S. Germline and Somatic Whole-Exome Sequencing Identifies New Candidate Genes Involved in Familial Predisposition to Serrated Polyposis Syndrome. Cancers (Basel). 2021 Feb;13(4):929. PMID: 33672345. DOI: 10.3390/cancers13040929. http://www.ncbi.nlm.nih.gov/pubmed/33672345
Enlace

Vera R, Salgado M, Safont MJ, Gallego J, González E, Élez E, Aranda E. Controversies in the treatment of RAS wild-type metastatic colorectal cancer. Clin Transl Oncol. 2021 Apr;23(4):827–39. PMID: 32789773. DOI: 10.1007/s12094-020-02475-8. http://www.ncbi.nlm.nih.gov/pubmed/32789773
Enlace

Alustiza M, Hernández-Illán E, Juárez M, Giner-Calabuig M, Mira C, Martínez-Roca A, Bujanda L, Rodríguez-Moranta F, Cubiella J, De-Castro L, Marín-Gabriel J-C, Herreros-de-Tejada A, Fernández-Bañares F, Nicolás-Pérez D, Giménez P, Martínez-Cardona C, Francés R, Murcia O, Jover R. Increased Th17-Related Cytokine Serum Levels in Patients With Multiple Polyps of Unexplained Origin. Clin Transl Gastroenterol. 2020;11(3):e00143. PMID: 32352715. DOI: 10.14309/ctg.0000000000000143. http://www.ncbi.nlm.nih.gov/pubmed/32352715
Enlace

Arias Ron D, Labandeira CM, Cameselle García S, García Mata J, Salgado Fernández M. Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report. Case Rep Oncol. 2020;13(1):69–75. PMID: 32110222. DOI: 10.1159/000505237. http://www.ncbi.nlm.nih.gov/pubmed/32110222
Enlace

Arnau-Collell C, Soares de Lima Y, Díaz-Gay M, Muñoz J, Carballal S, Bonjoch L, Moreira L, Lozano JJ, Ocaña T, Cuatrecasas M, Díaz de Bustamante A, Castells A, Capellà G, Bujanda L, Cubiella J, Rodríguez-Alcalde D, Balaguer F, Ruiz-Ponte C, Valle L, Moreno V, Castellvi-Bel S. Colorectal cancer genetic variants are also associated with serrated polyposis syndrome susceptibility. J Med Genet. 2020;57(10):677–82. PMID: 32170005. DOI: 10.1136/jmedgenet-2019-106374. http://www.ncbi.nlm.nih.gov/pubmed/32170005
Enlace

Bermejo de Las Heras B, Cortes Ramon Y Cajal J, Galve Calvo E, de la Haba Rodriguez J, Garcia Mata J, Moreno Anton F, Pelaez Fernandez I, Rodriguez-Lescure A, Rodriguez Sanchez CA, Ruiz-Borrego M, Remak E, Barra M, Rivero M, Soto Alvarez J. The economic burden of metastatic breast cancer in Spain. Eur J Hosp Pharm Sci Pract. 2020;27(1):19–24. PMID: 32064084. DOI: 10.1136/ejhpharm-2017-001453. http://www.ncbi.nlm.nih.gov/pubmed/32064084
Enlace

Botana-Rial M, Vázquez-Iglesias L, Casado-Rey P, Cadena MP de la, Andrade-Olivié MA, Abal-Arca J, García-Nimo L, Ferreiro-Fernández L, Valdés-Cuadrado L, San-José ME, Rodríguez-Berrocal FJ, Fernández-Villar A. Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial. Sci Rep. 2020;10(1):5679. PMID: 32231227. DOI: 10.1038/s41598-020-62388-y. http://www.ncbi.nlm.nih.gov/pubmed/32231227
Enlace

Clos-Garcia M, Garcia K, Alonso C, Iruarrizaga-Lejarreta M, D’Amato M, Crespo A, Iglesias A, Cubiella J, Bujanda L, Falcón-Pérez JM. Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer. Cancers (Basel). 2020 May;12(5):1142. PMID: 32370168. DOI: 10.3390/cancers12051142. http://www.ncbi.nlm.nih.gov/pubmed/32370168
Enlace

Cubiella J, González A, Almazán R, Rodríguez-Camacho E, Fontenla Rodiles J, Domínguez Ferreiro C, Tejido Sandoval C, Sánchez Gómez C, de Vicente Bielza N, Lorenzo IP-R, Zubizarreta R. pT1 Colorectal Cancer Detected in a Colorectal Cancer Mass Screening Program: Treatment and Factors Associated with Residual and Extraluminal Disease. Cancers (Basel). 2020 Sep;12(9):2530. PMID: 32899974. DOI: 10.3390/cancers12092530. http://www.ncbi.nlm.nih.gov/pubmed/32899974
Enlace

Cubiella J. Not so FAST. Commentary on the article “Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study”. BMC Gastroenterol. 2020 Jul;20(1):231. PMID: 32690047. DOI: 10.1186/s12876-020-01322-y. http://www.ncbi.nlm.nih.gov/pubmed/32690047
Enlace

Fernandez Montes A, Vazquez Rivera F, Martinez Lago N, Covela Rúa M, Cousillas Castiñeiras A, Gonzalez Villarroel P, de la Cámara Gómez J, Méndez Méndez JC, Salgado Fernández M, Candamio Folgar S, Reboredo López M, Carmona Campos M, Gallardo Martín E, Jorge Fernández M, Pellón Augusto ML, París Bouzas L, García Gómez J. Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram. Clin Transl Oncol. 2020 Mar;22(3):351–9. PMID: 31073972. DOI: 10.1007/s12094-019-02130-x. http://www.ncbi.nlm.nih.gov/pubmed/31073972
Enlace

García-González J, Ruiz-Bañobre J, Afonso-Afonso FJ, Amenedo-Gancedo M, Areses-Manrique MDC, Campos-Balea B, Casal-Rubio J, Fernández-Núñez N, Fírvida Pérez JL, Lázaro-Quintela M, Pérez Parente D, Crama L, Ruiz-Gracia P, Santomé-Couto L, León-Mateos L. PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis. J Clin Med. 2020 Jul;9(7):2093. PMID: 32635291. DOI: 10.3390/jcm9072093. http://www.ncbi.nlm.nih.gov/pubmed/32635291
Enlace

González-Del-Alba A, Arranz JÁ, Bellmunt J, Maroto JP, Fernández-Calvo O, Valderrama BP, González-Billalabeitia E, Méndez-Vidal MJ, Cassinello J, Romero-Laorden N, Climent MÁ, Puente J, Peláez I, Lázaro-Quintela M, Gallardo E, Suárez C. Latest progress in molecular biology and treatment in genitourinary tumours. Clin Transl Oncol. 2020 Dec;22(12):2175–95. PMID: 32440915. DOI: 10.1007/s12094-020-02373-z. http://www.ncbi.nlm.nih.gov/pubmed/32440915
Enlace

Gutierrez-Stampa MA, Aguilar V, Sarasqueta C, Cubiella J, Portillo I, Bujanda L. Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test. Cancers (Basel). 2020 Aug;12(9):2412. PMID: 32854370. DOI: 10.3390/cancers12092412. http://www.ncbi.nlm.nih.gov/pubmed/32854370
Enlace

Gutierrez-Stampa MA, Aguilar V, Sarasqueta C, Cubiella J, Portillo I, Bujanda L. Impact of the faecal immunochemical test on colorectal cancer survival. BMC Cancer. 2020 Jul;20(1):616. PMID: 32611328. DOI: 10.1186/s12885-020-07074-y. http://www.ncbi.nlm.nih.gov/pubmed/32611328
Enlace

Lourido L, Ruiz-Romero C, Picchi F, Diz-Rosales N, Vilaboa-Galan S,Fernandez-Lopez C, Tasende JAP, Perez-Pampin E, Regueiro C, Mera-Varela A,Gonzalez A, Hambardzumyan K, Saevarsdottir S, Nilsson P, Blanco FJ. Associationof serum anti-centromere protein F antibodies with clinical response toinfliximab in patients with rheumatoid arthritis: A prospective study. SeminArthritis Rheum. 2020 Oct;50(5):1101-1108. doi: 10.1016/j.semarthrit.2020.06.010.Epub 2020 Jun 30. PubMed PMID: 32920323.

Mangas-Sanjuan C, Santana E, Cubiella J, Rodríguez-Camacho E, Seoane A, Alvarez-Gonzalez MA, Suárez A, Álvarez-García V, González N, Luè A, Cid-Gomez L, Ponce M, Bujanda L, Portillo I, Pellisé M, Díez-Redondo P, Herráiz M, Ono A, Pizarro Á, Zapater P, Jover R, QUALISCOPIA Study Investigators. Variation in Colonoscopy Performance Measures According to Procedure Indication. Clin Gastroenterol Hepatol. 2020 May;18(5):1216-1223.e2. PMID: 31446179. DOI: 10.1016/j.cgh.2019.08.035. http://www.ncbi.nlm.nih.gov/pubmed/31446179
Enlace

Méndez Méndez JC, Salgado Fernández M, de la Cámara Gómez J, Pellón Augusto ML, Covela Rua M, Quintero Aldana G, Fernández Montes A, Reboredo López M, Valladares Ayerbes M, Jorge Fernández M, González Villarroel P, Romero Reinoso C, Ramos Vázquez M, Galician Research Group on Digestive Tumours (GITuD). First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study. J Geriatr Oncol. 2020;11(8):1263–7. PMID: 32580916. DOI: 10.1016/j.jgo.2020.06.003. http://www.ncbi.nlm.nih.gov/pubmed/32580916
Enlace

Muñoz Martín AJ, Gallardo Díaz E, García Escobar I, Macías Montero R, Martínez-Marín V, Pachón Olmos V, Pérez Segura P, Quintanar Verdúguez T, Salgado Fernández M. SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019). Clin Transl Oncol. 2020 Feb;22(2):171–86. PMID: 31981080. DOI: 10.1007/s12094-019-02263-z. http://www.ncbi.nlm.nih.gov/pubmed/31981080
Enlace

Otero-Estévez O, Gallardo-Gomez M, Cadena MP de la, Rodríguez-Berrocal FJ, Cubiella J, Ramirez VH, García-Nimo L, Chiara L De. Value of Serum NEUROG1 Methylation for the Detection of Advanced Adenomas and Colorectal Cancer. Diagnostics (Basel, Switzerland). 2020 Jun;10(7) PMID: 32605302. DOI: 10.3390/diagnostics10070437. http://www.ncbi.nlm.nih.gov/pubmed/32605302
Enlace

Picó MD, Castillejo A, Murcia Ó, Giner-Calabuig M, Alustiza M, Sánchez A, Moreira L, Pellise M, Castells A, Carrillo-Palau M, Ramon Y Cajal T, Gisbert-Beamud A, Llort G, Yagüe C, López-Fernández A, Alvarez-Urturi C, Cubiella J, Rivas L, Rodríguez-Alcalde D, Herraiz M, Garau C, Dolz C, Bujanda L, Cid L, Povés C, Garzon M, Salces I, Ponce M, Hernández-Villalba L, Alenda C, Balaguer F, Soto J-L, Jover R. Clinical and Pathological Characterization of Lynch-Like Syndrome. Clin Gastroenterol Hepatol. 2020 Feb;18(2):368-374.e1. PMID: 31220642. DOI: 10.1016/j.cgh.2019.06.012. https://pubmed.ncbi.nlm.nih.gov/31220642/
Enlace

Picó MD, Sánchez-Heras AB, Castillejo A, Giner-Calabuig M, Alustiza M, Sánchez A, Moreira L, Pellise M, Castells A, Llort G, Yagüe C, Ramon Y Cajal T, Gisbert-Beamud A, Cubiella J, Rivas L, Herraiz M, Garau C, Salces I, Carrillo-Palau M, Bujanda L, López-Fernández A, Alvarez-Urturi C, López MJ, Alenda C, Zapater P, Lacueva FJ, Balaguer F, Soto J-L, Murcia Ó, Jover R. Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome. Cancers (Basel). 2020 Aug;12(8) PMID: 32784934. DOI: 10.3390/cancers12082225. http://www.ncbi.nlm.nih.gov/pubmed/32784934
Enlace

Pin-Vieito N, Iglesias MJ, Remedios D, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Martínez-Bauer E, Campo R, Bujanda L, Ferrández Á, Piñol V, Rodríguez-Alcalde D, Menéndez-Rodríguez M, García-Morales N, Pérez-Mosquera C, Cubiella J. Predictive Value of Carcinoembryonic Antigen in Symptomatic Patients without Colorectal Cancer: A Post-Hoc Analysis within the COLONPREDICT Cohort. Diagnostics (Basel, Switzerland). 2020 Dec;10(12):1036. PMID: 33276621. DOI: 10.3390/diagnostics10121036. http://www.ncbi.nlm.nih.gov/pubmed/33276621
Enlace

Pin-Vieito N, Iglesias MJ, Remedios D, Rodríguez-Alonso L, Rodriguez-Moranta F, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Martínez-Bauer E, Campo R, Bujanda L, Ferrandez Á, Piñol V, Rodríguez-Alcalde D, Guardiola J, Cubiella J, On Behalf Of The Colonpredict Study Investigators. Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test. World J Gastroenterol. 2020 Jan;26(1):70–85. PMID: 31933515. DOI: 10.3748/wjg.v26.i1.70. http://www.ncbi.nlm.nih.gov/pubmed/31933515
Enlace

Quintero Aldana G, Salgado M, Candamio S, Méndez JC, Jorge M, Reboredo M, Vázquez Tuñas L, Romero C, Covela M, Fernández Montes A, Carmona M, Vidal Insua Y, López R, Galician Oncological Research Group (GGIO). First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial. Clin Transl Oncol. 2020 Apr;22(4):495–502. PMID: 31280434. DOI: 10.1007/s12094-019-02151-6. http://www.ncbi.nlm.nih.gov/pubmed/31280434
Enlace

Regueiro C, Rodriguez-Rodriguez L, Lopez-Mejias R, Nuno L, Triguero-MartinezA, Perez-Pampin E, Corrales A, Villalba A, Lopez-Golan Y, Abasolo L,Remuzgo-Martinez S, Ortiz AM, Herranz E, Martinez-Feito A, Conde C, Mera-VarelaA, Balsa A, Gonzalez-Alvaro I, Gonzalez-Gay MA, Fernandez-Gutierrez B, GonzalezA. A predominant involvement of the triple seropositive patients and others withrheumatoid factor in the association of smoking with rheumatoid arthritis. SciRep. 2020 Feb 25;10(1):3355. doi: 10.1038/s41598-020-60305-x. Erratum In: SciRep. 2020 Oct 22;10(1):18372. doi: 10.1038/s41598-020-75520-9. PubMed PMID:32098994; PubMed Central PMCID: PMC7042270.

Rivero-Sánchez L, Arnau-Collell C, Herrero J, Remedios D, Cubiella J, García-Cougil M, Alvarez V, Albéniz E, Calvo P, Gordillo J, Puig I, López-Vicente J, Huerta A, López-Cerón M, Salces I, Peñas B, Parejo S, Rodriguez de Santiago E, Herraiz M, Carretero C, Gimeno-Garcia AZ, Saperas E, Alvarez-Urturi C, Moreira R, Rodriguez de Miguel C, Ocaña T, Moreira L, Carballal S, Sánchez A, Jung G, Castells A, Llach J, Balaguer F, Pellisé M, EndoCAR group from Spanish Gastroenterology Association (AEG) and Spanish Society of Digestive Endoscopy (SEED). White-Light Endoscopy Is Adequate for Lynch Syndrome Surveillance in a Randomized and Noninferiority Study. Gastroenterology. 2020;158(4):895-904.e1. PMID: 31520613. DOI: 10.1053/j.gastro.2019.09.003. http://www.ncbi.nlm.nih.gov/pubmed/31520613
Enlace

Rodriguez-Martinez L, Bang H, Regueiro C, Nuno L, Triguero-Martinez A,Peiteado D, Ortiz AM, Villalba A, Martinez-Feito A, Balsa A, Gonzalez-Alvaro I,Gonzalez A. Improved classification of rheumatoid arthritis with a scoreincluding anti-acetylated ornithine antibodies. Sci Rep. 2020 Nov 6;10(1):19263.doi: 10.1038/s41598-020-73919-y. PubMed PMID: 33159095; PubMed Central PMCID:PMC7648756.

Ron DA, Vera R, Labandeira CM, Manrique MCA, Núñez MÁ, Cid NG, Mata JG, Montes AF. Maintenance treatment in metastatic colorectal cancer: in search of the best strategy. Clin Transl Oncol. 2020 Aug;22(8):1205–15. PMID: 31898053. DOI: 10.1007/s12094-019-02267-9. http://www.ncbi.nlm.nih.gov/pubmed/31898053
Enlace

Rutter MD, Bretthauer M, Hassan C, Jover R, WEO Surveillance Working Group (Joaquín Cubiella). Principles for Evaluation of Surveillance After Removal of Colorectal Polyps: Recommendations From the World Endoscopy Organization. Gastroenterology. 2020;158(6):1529-1533.e4. PMID: 32240700. DOI: 10.1053/j.gastro.2019.12.052. http://www.ncbi.nlm.nih.gov/pubmed/32240700
Enlace

Toma C, Díaz-Gay M, Franch-Expósito S, Arnau-Collell C, Overs B, Muñoz J, Bonjoch L, Soares de Lima Y, Ocaña T, Cuatrecasas M, Castells A, Bujanda L, Balaguer F, Cubiella J, Caldés T, Fullerton JM, Castellví-Bel S. Using linkage studies combined with whole-exome sequencing to identify novel candidate genes for familial colorectal cancer. Int J cancer. 2020;146(6):1568–77. PMID: 31525256. DOI: 10.1002/ijc.32683. http://www.ncbi.nlm.nih.gov/pubmed/31525256
Enlace

Vera R, Gómez ML, Ayuso JR, Figueras J, García-Alfonso P, Martínez V, Lacasta A, Ruiz-Casado A, Safont MJ, Aparicio J, Campos JM, Cámara JC, Martín-Richard M, Montagut C, Pericay C, Vieitez JM, Falcó E, Jorge M, Marín M, Salgado M, Viúdez A. Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study. Cancers (Basel). 2020 Aug;12(8) PMID: 32806731. DOI: 10.3390/cancers12082259. http://www.ncbi.nlm.nih.gov/pubmed/32806731
Enlace

Anido-Herranz U, Fernández-Núñez N, Afonso-Afonso J, Santomé-Couto L, Medina-Colmenero A, Fernández-Calvo O, Lázaro-Quintela M, Vázquez S. Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer. Clin Transl Oncol. 2019 Mar;21(3):249–58. PMID: 30051212. DOI: 10.1007/s12094-018-1928-y. http://www.ncbi.nlm.nih.gov/pubmed/30051212
Enlace

Arias Ron D, Labandeira CM, Areses Manrique MC, Sampedro Domarco P, Abdulkader I, García-Mata J, Rolfo C, González-Rivas D, Fírvida JL. Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report. Front Oncol. 2019 Sep;9(September):1–8. PMID: 31552167. DOI: 10.3389/fonc.2019.00819. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743439/pdf/fonc-09-00819.pdf
Enlace

Cameselle-García S, Pérez JLF, Areses MC, de Castro JDF, Mosquera-Reboredo J, García-Mata J. Primary malignant melanoma of the biliary tract: A case report and literature review. World J Clin cases. 2019 Aug;7(16):2302–8. PMID: 31531323. DOI: 10.12998/wjcc.v7.i16.2302. http://www.ncbi.nlm.nih.gov/pubmed/31531323
Enlace

Carmona-Bayonas A, Jimenez-Fonseca P, Garrido M, Custodio A, Hernandez R, Lacalle A, Cano JM, Aguado G, Martínez de Castro E, Alvarez Manceñido F, Macias I, Visa L, Martín Richard M, Mangas M, Sánchez Cánovas M, Longo F, Iglesias Rey L, Martínez Lago N, Martín Carnicero A, Sánchez A, Azkárate A, Limón ML, Hernández Pérez C, Ramchandani A, Pimentel P, Cerdá P, Serrano R, Gil-Negrete A, Marín M, Hurtado A, Sánchez Bayona R, Gallego J. Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer. Thromb Haemost. 2019 Nov;119(11):1849–59. PMID: 31461750. DOI: 10.1055/s-0039-1694012. http://www.ncbi.nlm.nih.gov/pubmed/31461750
Enlace

Carmona-Bayonas A, Jiménez-Fonseca P, Lamarca Á, Barriuso J, Castaño Á, Benavent M, Alonso V, Riesco-Martínez MDC, Alonso-Gordoa T, Custodio A, Sánchez Cánovas M, Hernando Cubero J, López C, Lacasta A, Fernández Montes A, Marazuela M, Crespo G, Escudero P, Diaz JÁ, Feliciangeli E, Gallego J, Llanos M, Segura Á, Vilardell F, Percovich JC, Grande E, Capdevila J, Valle JW, García-Carbonero R. Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study. J Clin Oncol. 2019;37(28):2571–80. PMID: 31390276. DOI: 10.1200/JCO.19.00980. http://www.ncbi.nlm.nih.gov/pubmed/31390276
Enlace

Díaz-Gay M, Franch-Expósito S, Arnau-Collell C, Park S, Supek F, Muñoz J, Bonjoch L, Gratacós-Mulleras A, Sánchez-Rojas PA, Esteban-Jurado C, Ocaña T, Cuatrecasas M, Vila-Casadesús M, Lozano JJ, Parra G, Laurie S, Beltran S, EPICOLON Consortium, Castells A, Bujanda L, Cubiella J, Balaguer F, Castellví-Bel S. Integrated Analysis of Germline and Tumor DNA Identifies New Candidate Genes Involved in Familial Colorectal Cancer. Cancers (Basel). 2019;11(3):1–16. PMID: 30871259. DOI: 10.3390/cancers11030362. http://www.ncbi.nlm.nih.gov/pubmed/30871259
Enlace

Dobarro Castro B, Remedios Espino DR, Tejido Sandoval C, Cubiella Fernández J. Therapeutic profitability of centralising the evaluation and treatment of complex polyps. Gastroenterol Hepatol. 2019 Dec;42(10):648–9. PMID: 31324466. DOI: 10.1016/j.gastrohep.2019.03.011. http://www.ncbi.nlm.nih.gov/pubmed/31324466
Enlace

Fernández Montes A, López López C, Argilés Martínez G, Páez López D, López Muñoz AM, García Paredes B, Gutiérrez Abad D, Castañón López C, Jiménez Fonseca P, Gallego Plazas J, López Doldán MC, Martínez de Castro E, Sánchez Cánovas M, Tobeña Puyal M, Llorente Ayala B, Juez Martel I, López Flores M, Carmona-Bayonas A. Prognostic Nomogram and Patterns of Use of FOLFIRI-Aflibercept in Advanced Colorectal Cancer: A Real-World Data Analysis. Oncologist. 2019;24(8):e687–95. PMID: 31147489. DOI: 10.1634/theoncologist.2018-0824. http://www.ncbi.nlm.nih.gov/pubmed/31147489
Enlace

Fernández Montes A, Martínez Lago N, Covela Rúa M, de la Cámara Gómez J, González Villaroel P, Méndez Méndez JC, Jorge Fernández M, Salgado Fernández M, Reboredo López M, Quintero Aldana G, Luz Pellón Augusto M, Graña Suárez B, García Gómez J. Efficacy and safety of FOLFIRI/aflibercept in second-line treatment of metastatic colorectal cancer in a real-world population: Prognostic and predictive markers. Cancer Med. 2019 Mar;8(3):882–9. PMID: 30690930. DOI: 10.1002/cam4.1903. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434192/pdf/CAM4-8-882.pdf
Enlace

Fernández-de Castro JD, Baiocchi Ureta F, Fernández González R, Pin Vieito N, Cubiella Fernández J. The effect of diagnostic delay attributable to the healthcare system on the prognosis of colorectal cancer. Gastroenterol Hepatol. 2019 Nov;42(9):527–33. PMID: 31421857. DOI: 10.1016/j.gastrohep.2019.03.012. http://www.ncbi.nlm.nih.gov/pubmed/31421857
Enlace

Font A, Luque R, Villa JC, Domenech M, Vázquez S, Gallardo E, Virizuela JA, Beato C, Morales-Barrera R, Gelabert A, Maciá S, Puente J, Rubio G, Maldonado X, Perez-Valderrama B, Pinto A, Fernández Calvo O, Grande E, Garde-Noguera J, Fernández-Parra E, Arranz JÁ. The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG). Target Oncol. 2019;14(1):15–32. PMID: 30694442. DOI: 10.1007/s11523-019-00619-7. http://www.ncbi.nlm.nih.gov/pubmed/30694442
Enlace

Herreros-Villanueva M, Duran-Sanchon S, Martín AC, Pérez-Palacios R, Vila-Navarro E, Marcuello M, Diaz-Centeno M, Cubiella J, Diez MS, Bujanda L, Lanas A, Jover R, Hernández V, Quintero E, José Lozano J, García-Cougil M, Martínez-Arranz I, Castells A, Gironella M, Arroyo R. Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer. Clin Transl Gastroenterol. 2019;10(1):e00003. PMID: 30702491. DOI: 10.14309/ctg.0000000000000003. https://www.ncbi.nlm.nih.gov/30702491
Enlace

Malagón M, Ramió-Pujol S, Serrano M, Serra-Pagès M, Amoedo J, Oliver L, Bahí A, Mas-de-Xaxars T, Torrealba L, Gilabert P, Miquel-Cusachs JO, García-Nimo L, Saló J, Guardiola J, Piñol V, Cubiella J, Castells A, Aldeguer X, Garcia-Gil J. Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers. Aliment Pharmacol Ther. 2019;49(11):1410–20. PMID: 31025420. DOI: 10.1111/apt.15251. http://www.ncbi.nlm.nih.gov/pubmed/31025420
Enlace

Mangas-Sanjuan C, Jover R, Cubiella J, Marzo-Castillejo M, Balaguer F, Bessa X, Bujanda L, Bustamante M, Castells A, Diaz-Tasende J, Díez-Redondo P, Herráiz M, Mascort-Roca JJ, Pellisé M, Quintero E, Grupo de Cribado del Cáncer Colorrectal de la Sociedad Española de Epidemiología. Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update. Gastroenterol Hepatol. 2019 Mar;42(3):188–201. PMID: 30621911. DOI: 10.1016/j.gastrohep.2018.11.001. http://www.ncbi.nlm.nih.gov/pubmed/30621911
Enlace

Marín Barrera L, Muñoz Martín A, Ríos Herranz E, García-Escobar I, Beato C, Font C, Oncala Sibajas E, Revuelta Rodríguez A, Areses-Manrique MC, Rivas Jiménez V, Moreno Santos M, Ballaz Quincoces A, Gallego Gallego I, Elías Hernández T, Asensio Cruz M, García González G, Otero Candelera L. Calidad de vida relacionada con la salud en pacientes oncológicos con enfermedad tromboembólica venosa aguda sintomática. Diseño del estudio QCA (Quality of Life in Cancer). Rev española Patol torácica. 2019;31(4):249–58. https://www.rev-esp-patol-torac.com/resumen_articulo.php?id=279&idarticulo=1628&y=2019
Enlace

Marin-Barrera L, Muñoz-Martin AJ, Rios-Herranz E, Garcia-Escobar I, Beato C, Font C, Oncala-Sibajas E, Revuelta-Rodriguez A, Areses MC, Rivas-Jimenez V, Moreno-Santos MA, Ballaz-Quincoces A, Lopez-Saez J-B, Gallego I, Elias-Hernandez T, Asensio-Cruz MI, Chasco-Eguilaz L, Garcia-Gonzalez G, Estevez-Garcia P, Otero R, Lima-Alvarez J, Jara-Palomares L. A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) Study. Cancers (Basel). 2019 Dec;12(1) PMID: 31888065. DOI: 10.3390/cancers12010075. http://www.ncbi.nlm.nih.gov/pubmed/31888065
Enlace

Ortega-Granados AL, Artal-Cortes Á, Aguiar-Bujanda D, Oramas J, Fírvida JL, DE Castro J, Fuentes JC, Gordo R, Galán R, Trigo J, ASPET Study Investigators. Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer. Anticancer Res. 2019 Mar;39(3):1317–28. PMID: 30842164. DOI: 10.21873/anticanres.13244. http://www.ncbi.nlm.nih.gov/pubmed/30842164
Enlace

Pin Vieito N, Zarraquiños S, Cubiella J. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis. World J Gastroenterol. 2019 May;25(19):2383–401. PMID: 31148909. DOI: 10.3748/wjg.v25.i19.2383. http://www.ncbi.nlm.nih.gov/pubmed/31148909
Enlace

Puga M, Pallarès N, Velásquez-Rodríguez J, García-Sumalla A, Consiglieri CF, Busquets J, Laquente B, Calvo M, Fabregat J, Castellote J, Gornals JB. Endoscopic biliary drainage in unresectable biliary obstruction: the role of endoscopic ultrasound-guidance in a cohort study. Rev Esp Enferm Dig. 2019 Sep;111(9):683–9. PMID: 31333037. DOI: 10.17235/reed.2019.6225/2019. http://www.ncbi.nlm.nih.gov/pubmed/31333037
Enlace

Puig I, López-Cerón M, Arnau A, Rosiñol Ò, Cuatrecasas M, Herreros-de-Tejada A, Ferrández Á, Serra-Burriel M, Nogales Ó, Vida F, de Castro L, López-Vicente J, Vega P, Álvarez-González MA, González-Santiago J, Hernández-Conde M, Díez-Redondo P, Rivero-Sánchez L, Gimeno-García AZ, Burgos A, García-Alonso FJ, Bustamante-Balén M, Martínez-Bauer E, Peñas B, Pellise M, EndoCAR group SGA and the SDES (V HJC. Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps. Gastroenterology. 2019 Oct;156(1):75–87. PMID: 30296432. DOI: 10.1053/j.gastro.2018.10.004. http://www.ncbi.nlm.nih.gov/pubmed/30296432
Enlace

Regueiro C, Rodriguez-Martinez L, Nuno L, Ortiz AM, Villalba A,Pascual-Salcedo D, Martinez-Feito A, Gonzalez-Alvaro I, Balsa A, Gonzalez A.Improved RA classification among early arthritis patients with the concordantpresence of three RA autoantibodies: analysis in two early arthritis clinics.Arthritis Res Ther. 2019 Dec 11;21(1):280. doi: 10.1186/s13075-019-2079-4. PubMedPMID: 31829260; PubMed Central PMCID: PMC6907192.

Regueiro C, Rodriguez-Rodriguez L, Triguero-Martinez A, Nuno L, Castano-NunezAL, Villalva A, Perez-Pampin E, Lopez-Golan Y, Abasolo L, Ortiz AM, Herranz E,Pascual-Salcedo D, Martinez-Feito A, Boveda MD, Gomez-Reino JJ, Martin J,Gonzalez-Escribano MF, Fernandez-Gutierrez B, Balsa A, Gonzalez-Alvaro I,Gonzalez A. Specific Association of HLA-DRB1*03 With Anti-Carbamylated ProteinAntibodies in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2019Mar;71(3):331-339. doi: 10.1002/art.40738. Epub 2019 Jan 28. PubMed PMID:30277011.

Rodríguez-Alcalde D, Carballal S, Moreira L, Hernández L, Rodríguez-Alonso L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, Saperas E, López-Cerón M, Cuatrecasas M, López-Vicente J, Rivero-Sánchez L, Jung G, Vila-Casadesús M, Sánchez A, Castells A, Pellisé M, Balaguer F, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome. Endoscopy. 2019 Aug;51(2):142–51. PMID: 30068004. DOI: 10.1055/a-0656-5557. http://www.ncbi.nlm.nih.gov/pubmed/30068004
Enlace

Ruiz-Bañobre J, Areses-Manrique MC, Mosquera-Martínez J, Cortegoso A, Afonso-Afonso FJ, de Dios-Álvarez N, Fernández-Núñez N, Azpitarte-Raposeiras C, Amenedo M, Santomé L, Fírvida-Pérez JL, García-Campelo R, García-González J, Casal-Rubio J, Vázquez S. Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy. Transl lung cancer Res. 2019 Dec;8(6):1078–85. PMID: 32010585. DOI: 10.21037/tlcr.2019.11.07. http://www.ncbi.nlm.nih.gov/pubmed/32010585
Enlace

Sánchez-Rovira P, Zamora P, Salvador-Bofill J, Morales S, Martínez-Jáñez N, Martínez-de-Dueñas E, Lluch A, Illarramendi JJ, Gómez-Pardo P, Gavilá Gregori J, García-Palomo A, García-Mata J, Fernández Y, Del Barco S, de Juan A, Ciruelos E, Chacón JI, Calvo L, Barnadas A, Albanell J. Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists. J drug Assess. 2019;8(1):62–9. PMID: 31069129. DOI: 10.1080/21556660.2019.1604375. http://www.ncbi.nlm.nih.gov/pubmed/31069129
Enlace

Toma C, Díaz-Gay M, Soares de Lima Y, Arnau-Collell C, Franch-Expósito S, Muñoz J, Overs B, Bonjoch L, Carballal S, Ocaña T, Cuatrecasas M, Díaz de Bustamante A, Castells A, Bujanda L, Cubiella J, Balaguer F, Rodríguez-Alcalde D, Fullerton JM, Castellví-Bel S. Identification of a Novel Candidate Gene for Serrated Polyposis Syndrome Germline Predisposition by Performing Linkage Analysis Combined With Whole-Exome Sequencing. Clin Transl Gastroenterol. 2019;10(10):e00100. PMID: 31663907. DOI: 10.14309/ctg.0000000000000100. http://www.ncbi.nlm.nih.gov/pubmed/31663907
Enlace

Campos Balea B, Fernández Bouza E, Barbagelata López C, Brozos Vázquez EM, CAROU FRIEIRO, IRIA; Fernández Pérez I, Iglesias Rey L, Quindós Varela M, Carmona Campos M, Antolín Novoa S. Guía gallega de manejo de la trombosis asociada a cáncer. Rivera Gallego A, Lopez-Lopez R (eds.). Barcelona: Bubblegum Communication Services; 2019. Con el Aval de la Sociedad Oncológica de Galicia (. ISBN: 978-84-09-1419-4. https://runa.sergas.es/xmlui/handle/20.500.11940/12881
Enlace

Lamelo-Alfonsín F, Fernández-Calvo O, Charlín-Pato G. Guías clínicas Fisterra: Control de síntomas en cuidados paliativos. 2019. https://www.fisterra.com/guias-clinicas/control-sintomas-cuidados-paliativos/
Enlace

Albéniz E, Pellisé M, Gimeno García AZ, Lucendo AJ, Alonso Aguirre PA, Herreros de Tejada A, Álvarez MA, Fraile M, Herráiz Bayod M, López Rosés L, Martínez Ares D, Ono A, Parra Blanco A, Redondo E, Sánchez Yagüe A, Soto S, Díaz Tasende J, Montes Díaz M, Téllez MR, García O, Zuñiga Ripa A, Hernández Conde M, Alberca de Las Parras F, Gargallo C, Saperas E, Navas MM, Gordillo J, Ramos Zabala F, Echevarría JM, Bustamante M, González Haba M, González Huix F, González Suárez B, Vila Costas JJ, Guarner Argente C, Múgica F, Cobián J, Rodríguez Sánchez J, López Viedma B, Pin N, Marín Gabriel JC, Nogales Ó, de la Peña J, Navajas León FJ, León Brito H, Remedios D, Esteban JM, Barquero D, Martínez Cara JG, Martínez Alcalá F, Fernández Urién I, Valdivielso E, en nombre del Grupo Español de Resección Endoscópica de la Sociedad Española de Endoscopia Digestiva. Clinical guidelines for endoscopic mucosal resection of non-pedunculated colorectal lesions. Gastroenterol Hepatol. 2018 Mar;41(3):175–90. PMID: 29449039. DOI: 10.10
Enlace

Areses Manrique MC, Mosquera Martínez J, García González J, Afonso Afonso FJ, Lázaro Quintela M, Fernández Núñez N, Azpitarte Raposeiras C, Amenedo Gancedo M, Santomé Couto L, García Campelo MR, Muñoz Iglesias J, Cortegoso Mosquera A, Vilchez Simo R, Casal Rubio J, Campos Balea B, Carou Frieiro I, Alonso-Jaudenes Curbera G, Anido Herranz U, García Mata J, Fírvida Pérez JL. Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience. Transl lung cancer Res. 2018 Jun;7(3):404–15. PMID: 30050778. DOI: 10.21037/tlcr.2018.04.03. http://www.ncbi.nlm.nih.gov/pubmed/30050778
Enlace

Barreiro-de Acosta M, Marín-Jiménez I, Panadero A, Guardiola J, Cañas M, Gobbo Montoya M, Modino Y, Alcaín G, Bosca-Watts MM, Calvet X, Casellas F, Chaparro M, Fernández Salazar L, Ferreiro-Iglesias R, Ginard D, Iborra M, Manceñido N, Mañosa M, Merino O, Rivero M, Roncero O, Sempere L, Vega P, Zabana Y, Mínguez M, Nos P, Gisbert JP. Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn’s Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patien. Gastroenterol Hepatol. 2018 Feb;41(2):118–27. PMID: 29275001. DOI: 10.1016/j.gastrohep.2017.10.003. http://www.ncbi.nlm.nih.gov/pubmed/29275001
Enlace

Bujanda L, Sarasqueta C, Vega P, Salve M, Quintero E, Alvarez-Sánchez V, Fernández-Bañares F, Boadas J, Campo R, Garayoa A, Ferrandez A, Torrealba L, Rodríguez-Alcaide D, D’Amato M, Hernández V, Cubiella J. Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia. United Eur Gastroenterol J. 2018 Feb;6(1):123–30. PMID: 29435322. DOI: 10.1177/2050640617707094. http://www.ncbi.nlm.nih.gov/pubmed/29435322
Enlace

Carballal S, Maisterra S, López-Serrano A, Gimeno-García AZ, Vera MI, Marín-Garbriel JC, Díaz-Tasende J, Márquez L, Álvarez MA, Hernández L, De Castro L, Gordillo J, Puig I, Vega P, Bustamante-Balén M, Acevedo J, Peñas B, López-Cerón M, Ricart E, Cuatrecasas M, Jimeno M, Pellisé M, EndoCAR group of the Spanish Gastroenterological Association and Spanish Digestive Endoscopy Society. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD. Gut. 2018 Jan;67(1):70–8. PMID: 27612488. DOI: 10.1136/gutjnl-2016-312332. http://www.ncbi.nlm.nih.gov/pubmed/27612488
Enlace

Carot L, Castells A, Hernández C, Alvarez-Urturi C, Balaguer F, Lanas A, Cubiella J, Tasende JD, Jover R, Hernandez V, Carballo F, Bujanda L, Quintero E, Andreu M, Bessa X. Detection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial. United Eur Gastroenterol J. 2018 Dec;6(10):1527–37. PMID: 30574323. DOI: 10.1177/2050640618804722. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297927/pdf/10.1177_2050640618804722.pdf
Enlace

Costa Rivas M, Huidobro Vence G, Fírvida Pérez JL, Campos Balea B, García Gonzalez J, Lázaro Quintela M, Caeiro Muñoz M, Taboada Valladares B, Castro Gómez JE, Vázquez Estevez S, Afonso Afonso FJ, Azpitarte Raposeiras C, Amenedo Gancedo M, Casal Rubio J. Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group. Clin Transl Oncol. 2018 Nov;20(11):1467–73. PMID: 29696478. DOI: 10.1007/s12094-018-1880-x. http://www.ncbi.nlm.nih.gov/pubmed/29696478
Enlace

Cubiella J, Clos-Garcia M, Alonso C, Martinez-Arranz I, Perez-Cormenzana M, Barrenetxea Z, Berganza J, Rodríguez-Llopis I, D’Amato M, Bujanda L, Diaz-Ondina M, Falcón-Pérez JM. Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer. Cancers (Basel). 2018 Sep;10(9):300. PMID: 30200467. DOI: 10.3390/cancers10090300. http://www.ncbi.nlm.nih.gov/pubmed/30200467
Enlace

Cubiella J, Marzo-Castillejo M, Mascort-Roca JJ, Amador-Romero FJ, Bellas-Beceiro B, Clofent-Vilaplana J, Carballal S, Ferrándiz-Santos J, Gimeno-García AZ, Jover R, Mangas-Sanjuán C, Moreira L, Pellisè M, Quintero E, Rodríguez-Camacho E, Vega-Villaamil P, Sociedad Española de Medicina de Familia y Comunitaria y Asociación Española de Gastroenterología. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 2018 Update. Gastroenterol Hepatol. 2018 Nov;41(9):585–96. PMID: 30245076. DOI: 10.1016/j.gastrohep.2018.07.012. http://www.ncbi.nlm.nih.gov/pubmed/30245076
Enlace

Esteban I, Vilaró M, Adrover E, Angulo A, Carrasco E, Gadea N, Sánchez A, Ocaña T, Llort G, Jover R, Cubiella J, Servitja S, Herráiz M, Cid L, Martínez S, Oruezábal-Moreno MJ, Garau I, Khorrami S, Herreros-de-Tejada A, Morales R, Cano JM, Serrano R, López-Ceballos MH, González-Santiago S, Juan-Fita MJ, Alonso-Cerezo C, Casas A, Graña B, Teulé A, Alba E, Antón A, Guillén-Ponce C, Sánchez-Heras AB, Alés-Martínez JE, Brunet J, Balaguer F, Balmaña J. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain. Psychooncology. 2018 Jun;27(6):1530–7. PMID: 29498768. DOI: 10.1002/pon.4686. http://www.ncbi.nlm.nih.gov/pubmed/29498768
Enlace

Fernández A, Salgado M, García A, Buxò E, Vera R, Adeva J, Jiménez-Fonseca P, Quintero G, Llorca C, Cañabate M, López LJ, Muñoz A, Ramírez P, González P, López C, Reboredo M, Gallardo E, Sanchez-Cánovas M, Gallego J, Guillén C, Ruiz-Miravet N, Navarro-Pérez V, De la Cámara J, Alés-Díaz I, Pazo-Cid RA, Carmona-Bayonas A. Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study. BMC Cancer. BMC Cancer; 2018 Nov;18(1):1185. PMID: 30497432. DOI: 10.1186/s12885-018-5101-3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267080/pdf/12885_2018_Article_5101.pdf
Enlace

Gallardo-Gómez M, Moran S, Páez de la Cadena M, Martínez-Zorzano VS, Rodríguez-Berrocal FJ, Rodríguez-Girondo M, Esteller M, Cubiella J, Bujanda L, Castells A, Balaguer F, Jover R, De Chiara L. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples. Clin Epigenetics. Clinical Epigenetics; 2018 Dec;10(1):53. PMID: 29686738. DOI: 10.1186/s13148-018-0487-y. http://www.ncbi.nlm.nih.gov/pubmed/29686738
Enlace

Gándara-Cortes M, Vázquez-Boquete Á, Fernández-Rodríguez B, Viaño P, Ínsua D, Seoane-Seoane A, Gude F, Gallego R, Fraga M, Antúnez JR, Curiel T, Pérez-López E, García-Caballero T. Breast cancer subtype discrimination using standardized 4-IHC and digital image analysis. Virchows Arch. 2018 Feb;472(2):195–203. PMID: 28825136. DOI: 10.1007/s00428-017-2194-z. IF2016: 2.848; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28825136
Enlace

García-Alfonso P, Benavides M, Falcó E, Muñoz A, Gómez A, Sastre J, Rivera F, Montagut C, Salgado M, López-Ladrón A, López R, Ruiz de Mena I, Durán G, Aranda E, Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD). Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial). Oncologist. 2018 Aug;23(11):1271-e128. PMID: 30120161. DOI: 10.1634/theoncologist.2018-0316. http://www.ncbi.nlm.nih.gov/pubmed/30120161
Enlace

García-Mata J, Álamo C, de Castro J, Contreras J, Gálvez R, Jara C, Llombart A, Pérez C, Sánchez P, Traseira S, Cruz J-J. A survey of perceptions, attitudes, knowledge and practices of medical oncologists about cancer pain management in Spain. Clin Transl Oncol. 2018 Aug;20(8):1061–71. PMID: 29721765. DOI: 10.1007/s12094-017-1826-8. http://www.ncbi.nlm.nih.gov/pubmed/29721765
Enlace

Herrero J-M, Vega P, Salve M, Bujanda L, Cubiella J. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study. BMC Gastroenterol. 2018 Oct;18(1):155. PMID: 30359225. DOI: 10.1186/s12876-018-0887-7. http://www.ncbi.nlm.nih.gov/pubmed/30359225
Enlace

López-Vicente J, Rodríguez-Alcalde D, Hernández L, Riu Pons F, Vega P, Herrero Rivas JM, Santiago García J, Salces Franco I, Bustamante Balén M, López-Cerón M, Pellisé M, Endoscopy for High Risk Cancer Conditions group of the Spanish Gastroenterological Association and Spanish Digestive Endoscopy Society. Panchromoendoscopy Increases Detection of Polyps in Patients With Serrated Polyposis Syndrome. Clin Gastroenterol Hepatol. 2018 Sep;17(10):2016-2023.e6. PMID: 30366156. DOI: 10.1016/j.cgh.2018.10.029. http://www.ncbi.nlm.nih.gov/pubmed/30366156
Enlace

Mangas-Sanjuan C, Zapater P, Cubiella J, Murcia Ó, Bujanda L, Hernández V, Martínez-Ares D, Pellisé M, Seoane A, Lanas Á, Nicolás-Pérez D, Herreros-de-Tejada A, Chaparro M, Cacho G, Fernández-Díez S, Marín-Gabriel J-C, Quintero E, Castells A, Jover R, COLONPREV study investigators (Susana Aldecoa; Carlos Menéndez). Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox. United Eur Gastroenterol J. 2018 May;6(4):622–9. PMID: 29881618. DOI: 10.1177/2050640617745458. http://www.ncbi.nlm.nih.gov/pubmed/29881618
Enlace

Maximiano C, López I, Martín C, Zugazabeitia L, Martí-Ciriquián JL, Núñez MA, Contreras J, Herdman M, Traseira S, Provencio M. An exploratory, large-scale study of pain and quality of life outcomes in cancer patients with moderate or severe pain, and variables predicting improvement. PLoS One. 2018;13(4):e0193233. PMID: 29614068. DOI: 10.1371/journal.pone.0193233. http://www.ncbi.nlm.nih.gov/pubmed/29614068
Enlace

Munoz Martin AJ, Ortega I, Font C, Pachon V, Castellon V, Martinez-Marin V, Salgado M, Martinez E, Calzas J, Ruperez A, Souto JC, Martin M, Salas E, Soria JM. Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer. Br J Cancer. Springer US; 2018 Apr;118(8):1056–61. PMID: 29588512. DOI: 10.1038/s41416-018-0027-8. http://www.ncbi.nlm.nih.gov/pubmed/29588512
Enlace

Sabell Pérez-Salgado F, Vázquez-Estévez S, Anido-Herranz U, Blanco-Parra M, Casas-Nebra FJ, Fernández-Calvo O, Lázaro-Quintela M, López-García S. Approach of the patient with renal cancer: Is there a collaboration between urology and oncology? Actas Urol Esp. 2018 Jan;42(1):1–4. PMID: 28587846. DOI: 10.1016/j.acuro.2017.04.001. http://www.ncbi.nlm.nih.gov/pubmed/28587846
Enlace

Visa L, Jiménez-Fonseca P, Asensio-Martínez E, Hernández R, Custodio A, Garrido M, Viudez A, Buxo E, Echavarria I, Cano JM, Macias I, Mangas M, Martínez-de Castro E, García T, Álvarez-Manceñido F, Fernández-Montes A, Azkarate A, Longo F, Díaz-Serrano A, López C, Hurtado A, Cerdá P, Serrano R, Gil-Negrete A, Martín-Carnicero A, Pimentel P, Ramchandani A, Carmona-Bayonas A. Efficacy and safety of chemotherapy in older versus non-older patients with advanced gastric cancer: A real-world data, non-inferiority analysis. J Geriatr Oncol. 2018 May;9(3):254–64. PMID: 29242093. DOI: 10.1016/j.jgo.2017.11.008. http://www.ncbi.nlm.nih.gov/pubmed/29242093
Enlace

Grupo de Trabajo Responsable de la Actualización de la GPC de Diagnóstico y Prevención del Cáncer Colorrectal (Joaquín Cubiella; Pablo Vega). Diagnóstico y prevención del cáncer colorrectal. Actualización 2018. Cubiella-Fernández J, Marzo-Castillejo M, Mascort-Roca JJ (eds.). Asociación Española de Gastroenterología y Sociedad Española de Medicina de Familia y Comunitaria; IMC; 2018. DL: M-29238-2018. ISBN: 978-84-7867-620-0. https://www.aegastro.es/sites/default/files/archivos/guia-clinica/actualizacion_prevencion_cancer_colorrectal.pdf
Enlace

Climent MÁ, Pérez-Valderrama B, Mellado B, Fernández Parra EM, Fernández Calvo O, Ochoa de Olza M, Muinelo Romay L, Anido U, Domenech M, Hernando Polo S, Arranz Arija JÁ, Caballero C, Juan Fita MJ, Castellano D. Weekly cabazitaxel plus prednisone is effective and less toxic for ‘unfit’ metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial. Eur J Cancer. 2017 Dec;87:30–7. PMID: 29102858. DOI: 10.1016/j.ejca.2017.09.028. IF2017: 7.191; Q1. http://www.ncbi.nlm.nih.gov/pubmed/29102858
Enlace

Cubiella J, Castells A, Andreu M, Bujanda L, Carballo F, Jover R, Lanas Á, Morillas JD, Salas D, Quintero E, COLONPREV study investigators (Susana Aldecoa; Inés Castro; Vicent Hernández; Carlos Menéndez). Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs. United Eur Gastroenterol J. 2017 Mar;5(2):255–60. PMID: 28344793. DOI: 10.1177/2050640616660662. IF2017: 3.477; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28344793
Enlace

Cubiella J, Digby J, Rodríguez-Alonso L, Vega P, Salve M, Díaz-Ondina M, Strachan JA, Mowat C, McDonald PJ, Carey FA, Godber IM, Younes H Ben, Rodriguez-Moranta F, Quintero E, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Campo R, Bujanda L, Garayoa A, Ferrandez Á, Piñol V, Rodríguez-Alcalde D, Guardiola J, Steele RJC, Fraser CG, COLONPREDICT study investigators. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients. Int J cancer. 2017 May;140(10):2201–11. PMID: 28187494. DOI: 10.1002/ijc.30639. IF2017: 7.360; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28187494
Enlace

Cueva JF, Antolín S, Calvo L, Fernández I, Ramos M, de Paz L, Mata JG, López R, Constenla M, Pérez E, González A, Pellón ML, Varela S, López T. Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention. Clin Transl Oncol. 2017 Sep;19(9):1067–78. PMID: 28342058. DOI: 10.1007/s12094-017-1648-8. IF2017: 2.392; Q3. http://www.ncbi.nlm.nih.gov/pubmed/28342058
Enlace

Custodio A, Carmona-Bayonas A, Jiménez-Fonseca P, Sánchez ML, Viudez A, Hernández R, Cano JM, Echavarria I, Pericay C, Mangas M, Visa L, Buxo E, García T, Rodríguez Palomo A, Álvarez Manceñido F, Lacalle A, Macias I, Azkarate A, Ramchandani A, Fernández-Montes A, López C, Longo F, Sánchez Bayona R, Limón ML, Díaz-Serrano A, Hurtado A, Madero R, Gómez C, Gallego J. Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab. Br J Cancer. 2017 Jun;116(12):1526–35. PMID: 28463962. DOI: 10.1038/bjc.2017.122. IF2017: 5.922; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28463962
Enlace

Egoavil C, Juárez M, Guarinos C, Rodríguez-Soler M, Hernández-Illán E, Alenda C, Payá A, Castillejo A, Serradesanferm A, Bujanda L, Fernández-Bañares F, Cubiella J, De-Castro L, Guerra A, Aguirre E, Herreros-de-Tejada A, Bessa X, Herráiz M, Marín-Gabriel J-C, Balmaña J, Piñol V, Rodríguez Moranta F, Nicolás-Pérez D, Cuatrecasas M, Balaguer F, Castells A, Soto J-L, Zapater P, Jover R. Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives. Gastroenterology. 2017 Jul;153(1):106-112.e2. PMID: 28400194. DOI: 10.1053/j.gastro.2017.04.003. IF2017: 20.773; D1. http://www.ncbi.nlm.nih.gov/pubmed/28400194
Enlace

Esteban-Jurado C, Giménez-Zaragoza D, Muñoz J, Franch-Expósito S, Álvarez-Barona M, Ocaña T, Cuatrecasas M, Carballal S, López-Cerón M, Marti-Solano M, Díaz-Gay M, van Wezel T, Castells A, Bujanda L, Balmaña J, Gonzalo V, Llort G, Ruiz-Ponte C, Cubiella J, Balaguer F, Aligué R, Castellví-Bel S. POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer. Oncotarget. 2017 Apr;8(16):26732–43. PMID: 28423643. DOI: 10.18632/oncotarget.15810. IF2017: 5.168; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28423643
Enlace

Marzo-Castillejo M, Cubiella-Fernández J, Mascort-Roca J, Pastor Rodriguez-Moñino A. [Primary care and detection of colorectal cancer]. Aten primaria. 2017 Dec;49(10):565–7. PMID: 29195689. DOI: 10.1016/j.aprim.2017.11.001. IF2017: 1.148; Q3. http://www.ncbi.nlm.nih.gov/pubmed/29195689
Enlace

Menéndez Villalva C, López Alvarez-Muiño XL, Gamarra Mondelo T, Alonso Fachado A, Cubiella Fernández J. Adherence to Treatment in Hypertension. Adv Exp Med Biol. 2017 Oct;956:129–47. PMID: 27757938. DOI: 10.1007/5584_2016_77. IF2017: 1.760; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27757938
Enlace

Mestres JA, IMolins AB, Martínez LC, López-Muñiz JIC, Gil EC, de Juan Ferré A, Del Barco Berrón S, Pérez YF, Mata JG, Palomo AG, Gregori JG, Pardo PG, Mañas JJI, Hernández AL, de Dueñas EM, Jáñez NM, Murillo SM, Bofill JS, Auñón PZ, Sanchez-Rovira P. Defining the optimal sequence for the systemic treatment of metastatic breast cancer. Clin Transl Oncol. 2017 Feb;19(2):149–61. PMID: 27314861. DOI: 10.1007/s12094-016-1520-2. IF2017: 2.392; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27314861
Enlace

Westwood M, Lang S, Armstrong N, van Turenhout S, Cubiella J, Stirk L, Ramos IC, Luyendijk M, Zaim R, Kleijnen J, Fraser CG. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance. BMC Med. 2017 Dec;15(1):189. PMID: 29061126. DOI: 10.1186/s12916-017-0944-z. IF2017: 9.088; D1. http://www.ncbi.nlm.nih.gov/pubmed/29061126
Enlace

Albéniz E, Fraile M, Ibáñez B, Alonso-Aguirre P, Martínez-Ares D, Soto S, Gargallo CJ, Ramos Zabala F, Álvarez MA, Rodríguez-Sánchez J, Múgica F, Nogales Ó, Herreros de Tejada A, Redondo E, Guarner-Argente C, Pin N, León-Brito H, Pardeiro R, López-Roses L, Rodríguez-Téllez M, Jiménez A, Martínez-Alcalá F, García O, de la Peña J, Ono A, Alberca de Las Parras F, Pellisé M, Rivero L, Saperas E, Pérez-Roldán F, Pueyo Royo A, Eguaras Ros J, Zúñiga Ripa A, Concepción-Martín M, Huelin-Álvarez P, Colán-Hernández J, Cubiella J, Remedios D, Bessa I Caserras X, López-Viedma B, Cobian J, González-Haba M, Santiago J, Martínez-Cara JG, Valdivielso E, Endoscopic Mucosal Resection Endoscopic Spanish Society Group. A Scoring System to Determine Risk of Delayed Bleeding After Endoscopic Mucosal Resection of Large Colorectal Lesions. Clin Gastroenterol Hepatol. 2016 Aug;14(8):1140–7. PMID: 27033428. DOI: 10.1016/j.cgh.2016.03.021. IF2016: 7.398; D1. http://www.ncbi.nlm.nih.gov/pubmed/27033428
Enlace

Alvarez-Urturi C, Andreu M, Hernandez C, Perez-Riquelme F, Carballo F, Ono A, Cruzado J, Cubiella JJ, Hernandez V, Mao CG, Perez E, Salas D, Andres M, Bujanda L, Portillo I, Sarasqueta C, Quintero E, Morillas JD, Lanas A, Sostres C, Auge JM, Castells A, Bessa X, Andrés M, Bujanda L, Portillo I, Sarasqueta C, Quintero E, Morillas JD, Lanas A, Sostres C, Augé JM, Castells A, Bessa X, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening. Dig Liver Dis. 2016 May;48(5):542–51. PMID: 26936343. DOI: 10.1016/j.dld.2016.02.001. IF2016: 3.061; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26936343
Enlace

Areses Manrique MC, Iglesias Rey L, Cubiella J. The long road from molecular biology to clinical practice in colorectal cancer. Gastroenterol Hepatol. 2016 Aug;39(7):429–32. PMID: 26847767. DOI: 10.1016/j.gastrohep.2015.11.005. IF2016: 0.917; Q4. http://www.ncbi.nlm.nih.gov/pubmed/26847767
Enlace

Baldaque-Silva F, Marques M, Sanchez-Hernandez E, Santos-Antunes J, Coelho R, Vilas-Boas F, Lopes J, Carneiro F, Macedo G. Endoscopic Submucosal Dissection of a Giant Esophageal Lipoma. Am J Gastroenterol. 2016 Dec;111(12):1680. PMID: 27924084. DOI: 10.1038/ajg.2016.272. IF2016: 9.566; D1. http://www.ncbi.nlm.nih.gov/pubmed/27924084
Enlace

Carballal S, Rodríguez-Alcalde D, Moreira L, Hernández L, Rodríguez L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, López-Cerón M, Cuatrecasas M, López-Vicente J, Leoz ML, Rivero-Sánchez L, Castells A, Pellisé M, Balaguer F, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study. Gut. 2016 Nov;65(11):1829–37. PMID: 26264224. DOI: 10.1136/gutjnl-2015-309647. IF2016: 16.658; D1. http://www.ncbi.nlm.nih.gov/pubmed/26264224
Enlace

Carmona-Bayonas A, Jiménez-Fonseca P, Lorenzo MLS, Ramchandani A, Martínez EA, Custodio A, Garrido M, Echavarría I, Cano JM, Barreto JEL, García TG, Manceñido FÁ, Lacalle A, Cardona MF, Mangas M, Visa L, Buxó E, Azkarate A, Díaz-Serrano A, Montes AF, Rivera F. On the Effect of Triplet or Doublet Chemotherapy in Advanced Gastric Cancer: Results From a National Cancer Registry. J Natl Compr Canc Netw. 2016 Nov;14(11):1379–88. PMID: 27799509. IF2016: 4.675; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27799509
Enlace

Cubiella J, Carballo F, Portillo I, Cruzado Quevedo J, Salas D, Binefa G, Milà N, Hernández C, Andreu M, Terán Á, Arana-Arri E, Ono A, Valverde MJ, Bujanda L, Hernández V, Morillas JD, Jover R, Castells A. Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines. Endoscopy. 2016 Nov;48(11):995–1002. PMID: 27485482. DOI: 10.1055/s-0042-112571. IF2016: 5.444; D1. http://www.ncbi.nlm.nih.gov/pubmed/27485482
Enlace

Cubiella J, Vega P, Salve M, Díaz-Ondina M, Alves MT, Quintero E, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Campo R, Bujanda L, Clofent J, Ferrandez Á, Torrealba L, Piñol V, Rodríguez-Alcalde D, Hernández V, Fernández-Seara J, COLONPREDICT study investigators. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients. BMC Med. 2016 Aug;14(1):128. PMID: 27580745. DOI: 10.1186/s12916-016-0668-5. IF2016: 7.901; D1. http://www.ncbi.nlm.nih.gov/pubmed/27580745
Enlace

Esteban-Jurado C, Franch-Expósito S, Muñoz J, Ocaña T, Carballal S, López-Cerón M, Cuatrecasas M, Vila-Casadesús M, Lozano JJ, Serra E, Beltran S, Brea-Fernández A, Ruiz-Ponte C, Castells A, Bujanda L, Garre P, Caldés T, Cubiella J, Balaguer F, Castellví-Bel S. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer. Eur J Hum Genet. 2016 Oct;24(10):1501–5. PMID: 27165003. DOI: 10.1038/ejhg.2016.44. IF2016: 4.287; Q1. http://www.ncbi.nlm.nih.gov/pubmed/27165003
Enlace

García J, Santomé L, Anido U, Fernández-Calvo O, Afonso-Afonso J, Lázaro M, Medina A, Vázquez Estévez S. Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU). Curr Oncol Rep. 2016 Dec;18(12):72. PMID: 27812861. DOI: 10.1007/s11912-016-0556-3. IF2016: 2.608; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27812861
Enlace

Jover R, Zapater P, Bujanda L, Hernández V, Cubiella J, Pellisé M, Ponce M, Ono A, Lanas A, Seoane A, Marín-Gabriel JC, Chaparro M, Cacho G, Herreros-de-Tejada A, Fernández-Díez S, Peris A, Nicolás-Pérez D, Murcia O, Castells A, Quintero E, COLONPREV Study Investigators (Susana Aldecoa; Inés Castro). Endoscopist characteristics that influence the quality of colonoscopy. Endoscopy. 2016 Mar;48(3):241–7. PMID: 26845473. DOI: 10.1055/s-0042-100185. IF2016: 5.444; D1. http://www.ncbi.nlm.nih.gov/pubmed/26845473
Enlace

Kastrinos F, Ojha RP, Leenen C, Alvero C, Mercado RC, Balmaña J, Valenzuela I, Balaguer F, Green R, Lindor NM, Thibodeau SN, Newcomb P, Win AK, Jenkins M, Buchanan DD, Bertario L, Sala P, Hampel H, Syngal S, Steyerberg EW, Lynch Syndrome prediction model validation study group (J Cubiella; V Hernández). Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer. J Natl Cancer Inst. 2016 Feb;108(2):1-9 (djv308). PMID: 26582061. DOI: 10.1093/jnci/djv308. IF2016: 12.589; D1. http://www.ncbi.nlm.nih.gov/pubmed/26582061
Enlace

Lainez N, García-Donas J, Esteban E, Puente J, Sáez MI, Gallardo E, Pinto-Marín Á, Vázquez-Estévez S, León L, García-Carbonero I, Suárez-Rodríguez C, Molins C, Climent-Duran MA, Lázaro-Quintela M, González Del Alba A, Méndez-Vidal MJ, Chirivella I, Afonso FJ, López-Brea M, Sala-González N, Domenech M, Basterretxea L, Santander-Lobera C, Gil-Arnáiz I, Fernández O, Caballero-Díaz C, Mellado B, Marrupe D, García-Sánchez J, Sánchez-Escribano R, Fernández Parra E, Villa Guzmán JC, Martínez-Ortega E, Belén González M, Morán M, Suarez-Paniagua B, Lecumberri MJ, Castellano D. Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study. BMC Cancer. 2016 Feb;16(1):135. PMID: 26906039. DOI: 10.1186/s12885-016-2084-9. IF2016: 3.288; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26906039
Enlace

Otero-Estévez O, De Chiara L, Barcia-Castro L, Páez de la Cadena M, Rodríguez-Berrocal FJ, Cubiella J, Hernández V, Martínez-Zorzano VS. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer. Sci Rep. Nature Publishing Group; 2016 May;6(November 2015):26703. PMID: 27222072. DOI: 10.1038/srep26703. IF2016: 4.259; Q1. http://www.ncbi.nlm.nih.gov/pubmed/27222072
Enlace

Pérez-López ME, García-Gómez J, Alves MT, Paradela A, García-Mata J, García-Caballero T. Ki-67 is a prognostic marker for hormone receptor positive tumors. Clin Transl Oncol. 2016 Oct;18(10):996–1002. PMID: 26742937. DOI: 10.1007/s12094-015-1472-y. IF2016: 2.353; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26742937
Enlace

Quintero E, Carrillo M, Leoz M-L, Cubiella J, Gargallo C, Lanas A, Bujanda L, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Morillas JD, Balaguer F, Muriel A, Oncology Group of the Asociación Española de Gastroenterología (AEG). Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study. PLoS Med. 2016 May;13(5):e1002008. PMID: 27138769. DOI: 10.1371/journal.pmed.1002008. IF2016: 11.862; D1. http://www.ncbi.nlm.nih.gov/pubmed/27138769
Enlace

Sánchez-Ares M, Cameselle-Teijeiro JM, Vázquez-Estévez S, Lázaro-Quintela M, Vázquez-Boquete Á, Afonso-Afonso FJ, Casal-Rubio J, González-Piñeiro AL, Rico-Rodríguez Y, Fírvida-Pérez JL, Ruíz-Bañobre J, Couso E, Santomé L, Pérez-Becerra R, García-Campelo R, Amenedo M, Azpitarte-Raposeiras C, Antúnez J, Abdulkader I. Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia). Oncol Lett. 2016 Aug;12(2):1403–7. PMID: 27446444. DOI: 10.3892/ol.2016.4788. IF2016: 1.390; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27446444
Enlace

Valentín F, Guarinos C, Juárez M, Rodríguez-Soler M, Serradesanferm A, Rodriguez-Moranta F, Nicolas-Perez D, Bujanda L, Herraiz M, De-Castro L, Fernández-Bañares F, Herreros-de-Tejada A, Martínez F, Aguirre E, Ferrández Á, Díaz-Tasende J, Piñol V, Paya A, Egoavil C, Alenda C, Castells A, Jover R, Cubiella J. Endoscopic surveillance in patients with multiple (10-100) colorectal polyps. Endoscopy. 2016 Jan;48(1):56–61. PMID: 26165738. DOI: 10.1055/s-0034-1392515. IF2016: 5.444; D1. http://www.ncbi.nlm.nih.gov/pubmed/26165738
Enlace

Vázquez S, Casal J, Afonso Afonso FJ, Fírvida JL, Santomé L, Barón F, Lázaro M, Pena C, Amenedo M, Abdulkader I, González-Arenas C, Fachal L, Vega A. EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10). Cancer Manag Res. 2016 Feb;8:11–20. PMID: 26893581. DOI: 10.2147/CMAR.S85173. IF2016: 3.851; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26893581
Enlace

Vera R, Dotor E, Feliu J, González E, Laquente B, Macarulla T, Martínez E, Maurel J, Salgado M, Manzano JL. SEOM Clinical Guideline for the treatment of pancreatic cancer (2016). Clin Transl Oncol. 2016 Dec;18(12):1172–8. PMID: 27896637. DOI: 10.1007/s12094-016-1586-x. IF2016: 2.353; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27896637
Enlace

Williams TGS, Cubiella J, Griffin SJ, Walter FM, Usher-Smith JA. Risk prediction models for colorectal cancer in people with symptoms: a systematic review. BMC Gastroenterol. BMC Gastroenterology; 2016 Jun;16(1):63. PMID: 27296358. DOI: 10.1186/s12876-016-0475-7. IF2016: 2.212; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27296358
Enlace

Crespo-Casal M. Infecciones causadas por el virus del herpes simple y de la Varicela-Zóster. In: Rozman Borstnar C, Cardellach Lo?pez F (eds.). Farreras-Rozman Medicina Interna (XVIII Edición). 18th ed. Barcelona: Elsevier Health Sciences Spain; 2016. p. 2313–6. ISBN: 978-84-9022-996-5. http://media.axon.es/pdf/109425.pdf
Enlace

Lamelo-Alfonsín F, Charlín-Pato G, Fernández-Calvo O. Fisterra Guías Clínicas: Nutrición en el paciente con cáncer. 2016. Revisión 2016. http://www.fisterra.com/guias-clinicas/nutricion-paciente-con-cancer/
Enlace

Anido Herranz U, Fernández Calvo O, Afonso Afonso FJ, Rodríguez Martínez de Llano S, Lázaro Quintela M, León Mateos L, Vázquez Estévez S, Antón Aparicio LM. Radium-223 dichloride: a new paradigm in the treatment of prostate cancer. Expert Rev Anticancer Ther. 2015 Mar;15(3):339–48. PMID: 25555355. DOI: 10.1586/14737140.2015.999045. IF2015: 2.094; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25555355
Enlace

Bujanda L, Sarasqueta C, Castells A, Pellisé M, Cubiella J, Gil I, Cosme A, Arana-Arri E, Mar I, Idigoras I, Portillo I, EUSCOLON Study Investigators. Colorectal cancer in a second round after a negative faecal immunochemical test. Eur J Gastroenterol Hepatol. 2015 Jul;27(7):813–8. PMID: 25856688. DOI: 10.1097/MEG.0000000000000366. IF2015: 2.093; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25856688
Enlace

Castro I, Estevez P, Cubiella J, Hernandez V, González-Mao C, Rivera C, Iglesias F, Cid L, Soto S, De-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Cid E, Gil I, Larzabal M, Bujanda L, Castells A, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms. Dig Dis Sci. 2015 May;60(5):1424–32. PMID: 25407805. DOI: 10.1007/s10620-014-3434-6. IF2015: 2.516; Q3. http://www.ncbi.nlm.nih.gov/pubmed/25407805
Enlace

Cubiella J. Quo vadis, NICE? Rev Esp Enferm Dig. 2015 May;107(5):253–4. PMID: 25952798. IF2015: 1.455; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25952798
Enlace

Fernández López MT, Fidalgo Baamil O, López Doldán C, Bardasco Alonso ML, de Sas Prada MT, Lagoa Labrador F, García García MJ, Mato Mato JA. [Prevalence of malnutrition in not critically ill older inpatients]. Nutr Hosp. 2015 Jun;31(6):2676–84. PMID: 26040381. DOI: 10.3305/nh.2015.31.6.8989. IF2015: 1.497; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26040381
Enlace

Otero-Estévez O, De Chiara L, Rodríguez-Berrocal FJ, Páez de la Cadena M, Cubiella J, Castro I, Gonzalez-Mao C, Hernández-Ramírez V, Martínez-Zorzano VS. Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test. Br J Cancer. 2015 Jan;112(2):375–81. PMID: 25461801. DOI: 10.1038/bjc.2014.605. IF2015: 5.569; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25461801
Enlace

Otero-Estévez O, De Chiara L, Rodríguez-Girondo M, Rodríguez-Berrocal FJ, Cubiella J, Castro I, Hernández V, Martínez-Zorzano VS. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening. Sci Rep. 2015 Aug;5:13030. PMID: 26264519. DOI: 10.1038/srep13030. IF2015: 5.228; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26264519
Enlace

Quintero-Aldana G, Jorge M, Grande C, Salgado-Fernández M, Gallardo E, Varela S, López C, Villanueva MJ, Fernández A, Alvarez E, González P, Castellanos J, Casal J, López R, Campos Balea B. Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer. Cancer Chemother Pharmacol. 2015 Oct;76(4):731–7. PMID: 26242221. DOI: 10.1007/s00280-015-2839-z. IF2015: 2.824; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26242221
Enlace

Salgado Fernández M, Pérez Hoyos MT, Díaz de Corcuera I, Vidal Arbués A, García de la Torre M. Aflibercept for metastatic colorectal cancer: safety data from the Spanish named patient program. Expert Opin Drug Saf. 2015 Aug;14(8):1171–9. PMID: 26076885. DOI: 10.1517/14740338.2015.1057495. IF2015: 2.896; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26076885
Enlace

Sastre J, Díaz-Beveridge R, García-Foncillas J, Guardeño R, López C, Pazo R, Rodriguez-Salas N, Salgado M, Salud A, Feliu J. Clinical guideline SEOM: hepatocellular carcinoma. Clin Transl Oncol. 2015 Dec;17(12):988–95. PMID: 26607931. DOI: 10.1007/s12094-015-1451-3. IF2015: 2.075; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26607931
Enlace

Turnes J, Díaz R, Hernandez-Guerra M, Gómez M, Castells L, Bustamante J, Espinosa MD, Fernández-Castroagudín J, Serrano T, Rendón P, Andrade R, Salgado M, Arenas J, Vergara M, Sala M, Polo BA, Granizo IM, Gonzálvez ML, Viudez A. [Therapeutic decisions in the treatment of hepatocellular carcinoma and patterns of sorafenib use. Results of the international observational GIDEON trial in Spain]. Gastroenterol Hepatol. 2015 Apr;38(4):263–73. PMID: 25583146. DOI: 10.1016/j.gastrohep.2014.11.001. IF2015: 0.800; Q4. http://www.ncbi.nlm.nih.gov/pubmed/25583146
Enlace

Vázquez S, Villanueva M, Fírvida J, Campos B, Lázaro M, Huidobro G, Areses M del, Fernández N, Covela M, Casal J. Erlotinib as Second-Line Therapy for Patients with Advanced Non-Small-Cell Lung Cancer and Wild-Type EGFR Tumors. J Anal Oncol. 2015 Sep;4(3):94–101. DOI: 10.6000/1927-7229.2015.04.03.1. IF2015: N/A. http://www.lifescienceglobal.com/journals/journal-of-analytical-oncology/volume-4-number-3/89-abstract/jao/1769-abstract-erlotinib-as-second-line-therapy-for-patients-with-advanced-non-small-cell-lung-cancer-and-wild-type-egfr-tumors
Enlace

Vega P, Valentín F, Cubiella J. Colorectal cancer diagnosis: Pitfalls and opportunities. World J Gastrointest Oncol. 2015 Dec;7(12):422–33. PMID: 26690833. DOI: 10.4251/wjgo.v7.i12.422. IF2015: N/A. http://www.ncbi.nlm.nih.gov/pubmed/26690833
Enlace

Brea-Fernández AJ, Cameselle-Teijeiro JM, Alenda C, Fernández-Rozadilla C, Cubiella-Fernández J, Clofent J, Reñé JM, Anido U, Milá M, Balaguer F, Castells A, Castellvi-Bel S, Jover R, Carracedo A, Ruiz-Ponte C. High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families. Clin Genet. 2014 Jun;85(6):583–8. PMID: 23837913. DOI: 10.1111/cge.12232. IF2014: 3.931; Q2. http://www.ncbi.nlm.nih.gov/pubmed/23837913
Enlace

Bujanda L, Sarasqueta C, Lanas Á, Quintero E, Cubiella J, Hernández-Ramírez V, Morillas JD, Perez-Fernández T, Salas D, Andreu M, Carballo F, Bessa X, Portillo I, Jover R, Balaguer F, Cosme A, Castells A, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Effect of oral anticoagulants on the outcome of faecal immunochemical test. Br J Cancer. 2014 Mar;110(5):1334–7. PMID: 24496455. DOI: 10.1038/bjc.2014.38. IF2014: 4.836; Q1. http://www.ncbi.nlm.nih.gov/pubmed/24496455
Enlace

Casal Rubio J, Fírvida-Pérez JL, Lázaro-Quintela M, Barón-Duarte FJ, Alonso-Jáudenes G, Santomé L, Afonso-Afonso FJ, Amenedo M, Huidobro G, Campos-Balea B, López-Vázquez MD, Vázquez S. A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study. Cancer Chemother Pharmacol. 2014 Mar;73(3):451–7. PMID: 24352251. DOI: 10.1007/s00280-013-2370-z. IF2014: 2.769; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24352251
Enlace

Castells A, Quintero E, Álvarez C, Bujanda L, Cubiella J, Salas D, Lanas A, Carballo F, Morillas JD, Hernández C, Jover R, Hijona E, Portillo I, Enríquez-Navascués JM, Hernández V, Martínez-Turnes A, Menéndez-Villalva C, González-Mao C, Sala T, Ponce M, Andrés M, Teruel G, Peris A, Sopeña F, González-Rubio F, Seoane-Urgorri A, Grau J, Serradesanferm A, Pozo À, Pellisé M, Balaguer F, Ono A, Cruzado J, Pérez-Riquelme F, Alonso-Abreu I, Carrillo-Palau M, de la Vega-Prieto M, Iglesias R, Amador J, Blanco JM, Sastre R, Ferrándiz J, González-Hernández MJ, Andreu M, Bessa X, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Rate of detection of advanced neoplasms in proximal colon by simulated sigmoidoscopy vs fecal immunochemical tests. Clin Gastroenterol Hepatol. 2014 Oct;12(10):1708-16.e4. PMID: 24681078. DOI: 10.1016/j.cgh.2014.03.022. IF2014: 7.896; D1. http://www.ncbi.nlm.nih.gov/pubmed/24681078
Enlace

Castro I, Cubiella J, Rivera C, González-Mao C, Vega P, Soto S, Hernandez V, Iglesias F, Teresa Alves M, Bujanda L, Fernández-Seara J. Fecal immunochemical test accuracy in familial risk colorectal cancer screening. Int J Cancer. 2014 Jan;134(2):367–75. PMID: 23818169. DOI: 10.1002/ijc.28353. IF2014: 5.085; Q1. http://www.ncbi.nlm.nih.gov/pubmed/23818169
Enlace

Cubiella J, Castro I, Hernandez V, González-Mao C, Rivera C, Iglesias F, Alves MT, Cid L, Soto S, De-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Estevez P, Cid E, Herreros-Villanueva M, Portillo I, Bujanda L, Fernández-Seara J. Diagnostic accuracy of fecal immunochemical test in average- and familial-risk colorectal cancer screening. United Eur Gastroenterol J. 2014 Dec;2(6):522–9. PMID: 25452848. DOI: 10.1177/2050640614553285. IF2014: 2.253; Q3. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4245302&tool=pmcentrez&rendertype=abstract
Enlace

Cubiella J, Castro I, Hernandez V, González-Mao C, Rivera C, Iglesias F, Cid L, Soto S, De-Castro L, Vega P, Hermo JA, Macenlle R, Martínez A, Martínez-Ares D, Estevez P, Cid E, Herreros-Villanueva M, Portillo I, Bujanda L, Fernández-Seara J, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Characteristics of adenomas detected by fecal immunochemical test in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1884–92. PMID: 24962836. DOI: 10.1158/1055-9965.EPI-13-1346. IF2014: 4.125; Q1. http://www.ncbi.nlm.nih.gov/pubmed/24962836
Enlace

Cubiella-Fernández J, Salve M, Díaz-Ondina M, Vega P, Alves MT, Iglesias F, Sánchez E, Macía P, Blanco I, Bujanda L, Fernández-Seara J. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria. Colorectal Dis. 2014 Aug;16(8):O273-82. PMID: 24456168. DOI: 10.1111/codi.12569. IF2014: 2.351; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24456168
Enlace

Fernandez-Plana J, Pericay C, Quintero G, Alonso V, Salud A, Mendez M, Salgado M, Saigi E, Cirera L, ACROSS Study Group. Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study). BMC Cancer. 2014 Nov;14:865. PMID: 25417182. DOI: 10.1186/1471-2407-14-865. IF2014: 3.362; Q2. http://www.ncbi.nlm.nih.gov/pubmed/25417182%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC4251687
Enlace

Gomez-Martín C, Lopez-Rios F, Aparicio J, Barriuso J, García-Carbonero R, Pazo R, Rivera F, Salgado M, Salud A, Vázquez-Sequeiros E, Lordick F. A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond. Cancer Lett. 2014 Aug;351(1):30–40. PMID: 24943493. DOI: 10.1016/j.canlet.2014.05.019. IF2014: 5.621; Q1. http://www.ncbi.nlm.nih.gov/pubmed/24943493
Enlace

Guarinos C, Juárez M, Egoavil C, Rodríguez-Soler M, Pérez-Carbonell L, Salas R, Cubiella J, Rodríguez-Moranta F, De-Castro L, Bujanda L, Serradesanferm A, Nicolás-Pérez D, Herráiz M, Fernández-Bañares F, Herreros-de-Tejada A, Aguirre E, Balmaña J, Rincón M-L, Pizarro A, Polo-Ortiz F, Castillejo A, Alenda C, Payá A, Soto J-L, Jover R. Prevalence and characteristics of MUTYH-associated polyposis in patients with multiple adenomatous and serrated polyps. Clin Cancer Res. 2014 Mar;20(5):1158–68. PMID: 24470512. DOI: 10.1158/1078-0432.CCR-13-1490. IF2014: 8.722; D1. http://www.ncbi.nlm.nih.gov/pubmed/24470512
Enlace

Hernandez V, Cubiella J, Gonzalez-Mao MC, Iglesias F, Rivera C, Iglesias MB, Cid L, Castro I, de Castro L, Vega P, Hermo JA, Macenlle R, Martínez-Turnes A, Martínez-Ares D, Estevez P, Cid E, Vidal MC, López-Martínez A, Hijona E, Herreros-Villanueva M, Bujanda L, Rodriguez-Prada JI, COLONPREV study investigators (Susana Aldecoa; Inés Castro). Fecal immunochemical test accuracy in average-risk colorectal cancer screening. World J Gastroenterol. 2014 Jan;20(4):1038–47. PMID: 24574776. DOI: 10.3748/wjg.v20.i4.1038. IF2014: 2.369; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24574776
Enlace

Luque M, Arranz F, Cueva JF, de Juan A, García-Teijido P, Calvo L, Peláez I, García-Palomo A, García-Mata J, Antolín S, García-Estévez L, Fernández Y. Breast cancer management in the elderly. Clin Transl Oncol. Springer Milan; 2014 Apr;16(4):351–61. PMID: 24085574. DOI: 10.1007/s12094-013-1113-2. IF2014: 2.077; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24085574
Enlace

Salas D, Vanaclocha M, Ibáñez J, Molina-Barceló A, Hernández-Ramírez V, Cubiella J, Zubizarreta R, Andreu M, Hernández C, Pérez-Riquelme F, Cruzado J, Carballo F, Bujanda L, Sarasqueta C, Portillo I, de la Vega-Prieto M, Morillas JD, Valentín V, Lanas A, Quintero E, Castells A. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening. Cancer Causes Control. 2014 Aug;25(8):985–97. PMID: 24859111. DOI: 10.1007/s10552-014-0398-y. IF2014: 2.735; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24859111
Enlace

Cubiella-Fernández J, Salgado M. Tumores del intestino delgado. In: Castells i Garangou A, Balaguer Prunés F (eds.). Cáncer digestivo: patogenia, diagnóstico, tratamiento y prevención. 1st ed. Barcelona: Elsevier; 2014. p. 35–49. ISBN: 9788490226834. https://tienda.elsevier.es/cancer-digestivo-patogenia-diagnostico-tratamiento-y-prevencion-9788490226834.html
Enlace